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ABSTRACT 
In this study, I conduct a multiple method content analysis of literature on postpartum 
depression (PPD) from two on-line sources, Medline and LexisNexis.  The purpose of the 
study is to determine how the medical profession defines and frames PPD, and to 
consider the implications of its movement into the medical model.  I use the theories of 
Foucault, Gramsci, critical constructionism, and postmodern feminism to examine the 
effect of the medicalization of PPD on women’s lives.  Using both simple descriptive 
statistics and qualitative analysis, I show the expansion of medical control over women’s 
bodies in the childbearing years beyond the physical to include the emotional and 
psychological aspects as well, which results in standardized maternal behaviors and 
emotions that tighten the boundaries of motherhood.   
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CHAPTER 1 
INTRODUCTION 
In June, 2001, Andrea Yates committed the unthinkable when she purposefully 
and methodically drowned her five children in a bathtub (Hamill 2001).  The shocking 
news of this tragedy inundated television broadcasts, newspapers, magazines, tabloids, 
and radio.  Perhaps the most shocking aspect of the tragedy is that Yates transgressed 
every traditional notion about motherhood.  She was charged with murder and faced a life 
sentence or possibly the death penalty.  Her defense attorneys claimed Yates suffered 
from temporary insanity due to postpartum depression (PPD), a condition which is the 
disease du jour associated with pregnancy and childbirth.  Although extreme, this case 
has become the hallmark for the potentially dangerous malady, prompting families and 
medical professionals to be alert to symptoms after the birth of a new baby.  Public 
awareness of PPD was heightened in 2005 when Tom Cruise, an actor and a member of 
the church of Scientology, publicly denied the benefits of medicating women with PPD 
and discredited the field of psychiatry in general.  He criticized actress/author Brooke 
Shields for her use of antidepressants during her recovery from PPD, provoking an 
exchange of opinions about the postpartum condition.     
But what exactly is postpartum depression?  Is it a disease?  Does it have 
biological roots – such as the dramatic change in hormones that occurs after giving birth 
–  or social causes – such as lack of support in the motherhood role?  Is it a real condition 
or is it a myth?  Information in both medical and popular sources portrays similar 
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characterization of the symptoms and treatments of the condition; however, a clear 
understanding of the causes of PPD is lacking.  Without knowing the causes of PPD, 
medical professionals devise treatments aimed at alleviating symptoms.  Such treatments 
typically include antidepressants or psychiatric counseling, or a combination of both 
(Puckering 2005; National Institute of Mental Health 2002; The National Women’s 
Health Information Center 2002).   
This study examines how the medical profession defines and frames PPD through 
a content analysis of articles contained in Medline, an on-line source for medical 
knowledge contained in the database of the U.S. National Library of Medicine (NLM), 
and with articles contained in the general news portion of LexisNexis.  The articles on 
Medline are generally written by medical professionals – doctors, nurses, psychiatrists, 
medical researchers, PhD’s, and others, and Medline is a particularly important source for 
analysis because of the authority which scientists and doctors wield.  Analysis of the 
articles on LexisNexis allows for a comparison between “scientific” and “lay” press 
representations of PPD.  Medline contains over 700 articles on PPD extending from 1950 
to the present, and LexisNexis contains over 1700 articles for the same time period.  To 
keep the study manageable, I examine a sample of articles chosen in five-year 
increments, beginning with 2005, then working back to 2000, 1995, 1990, and so on, 
back to 1950.  Examining the articles in five-year increments reveals changing definitions 
and frames over time, illustrating the increasing medicalization of PPD.       
This study is important for several reasons.  First, medicalization, a process which 
“organizes a broad and ever growing range of behaviors and aspects of everyday life into 
categories of health and illness” (Haritty & Tiefer 2003: 43) can be a means of social 
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control, promoted by medical experts and/or pharmaceutical companies with the ulterior 
motive to benefit professionally or economically from including PPD in the field of 
medicine (Haritty & Tiefer 2003; Conrad 1992).  Second, the medicalization of women’s 
issues, visible in such life events as childbirth, PMS, menopause, and increasingly 
postpartum depression, among others, tends to pathologize women and “reframes 
women’s experiences of their own lives and bodies” (Haritty & Tiefer 2003: 44).  For 
example, Murphy-Lawless (1998), in Reading Birth and Death: A History of Obstetric 
Thinking, chronicles the medicalization of childbirth, illustrating the power that scientific 
knowledge has in shaping women’s experiential knowledge of the birth process.  
Presenting women’s bodies as faulty, medical experts promoted their science as a means 
of lowering the risk of death for mother and baby (though it did not), which gave greater 
control to obstetric practices and greater authority to male-midwives and, later, 
obstetricians.  These practices “produced a complete scheme of labor management in 
1920” (Murphy-Lawless 1998:172) which is still practiced today, including that the 
hospital remains the preferred place of birth, that obstetricians use forceps when 
necessary or convenient, and that the typical birth position is horizontal and immobile.  In 
addition, episiotomies are routinely performed, drugs are available to ease the pain of 
labor, and the c-section rate is at an all-time high – 29.1percent of all births (Rubin 2005).  
Third, just as the medical profession uses fear to gain women’s compliance with 
obstetrics, analysis of the articles reveals that fear – of harm to the child, to the mother, to 
the family– is used to gain acceptance of PPD as a medical issue.  And finally, the 
articles reveal the extent to which other family members are considered vulnerable to 
PPD, expanding the scope of postpartum depression beyond the mother.    
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THEORETICAL BACKGROUND 
The theories of Foucault and Gramsci are applicable to the medicalization of 
PPD, as are critical constructionism and postmodern feminism.  Foucault asserts that 
truth is constructed through discourse in the activities of everyday life, and that nothing 
has meaning outside of discourse.  Individuals create and subscribe to regimes of truth, 
discursive formations that carry an assumption of authority with the power to deem 
knowledge as true or false, and they discipline and manage their bodies in order to 
perform according to these beliefs (Foucault 1979).   
The transformation to docility is achieved through disciplinary technologies that 
create the knowing, the knowable, and the self-knowing individual.  First, hierarchical 
observation categorizes, distributes, and creates a definition of what is normal or not 
normal, and the transformation of individuals to knowing individuals requires awareness 
of definitions of what is normal or not normal. Second, normalizing judgment allows 
understanding of self through biology, economics, and linguistics, with objectification of 
the body-as-thing complemented by the dividing practices instituted in spatial, temporal 
and social compartmentalizations.  Normalization is evident in national standards for 
educational programs, medical practices, and industrial processes and products.  And 
third, examination occurs as the individual turns self into subject, undergoing a process of 
self-understanding mediated by an external authority figure such as doctor, 
psychoanalyst, or priest (Foucault 1975).  In contemporary societies, discourse becomes 
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an effective means of social control, instrumental in managing conformity through its 
normative operations.  The process of separating the normal from the abnormal for the 
purpose of treating the abnormal serves as an enforcement of conformity for the normal 
rather than as punishment for the abnormal (Rabinow 1984).   
Similar to Foucault’s notion of conformity through docility, Gramsci’s notion of 
hegemony indicates the willing acceptance of one social group’s dominance and control 
by another through ideologies which become “common sense” in everyday practice.  
Gramsci maintains that power lies in the ability to gain willing participation through a 
combination of coercion and leading.  Political society, or the state, projects ideological 
beliefs that make individuals feel connected and think that they have something to gain in 
preserving order.  Civil society enforces the belief that individuals have something at 
stake and invokes conformity through the institutions of the family, the church, the 
media, education, and others.  Self-identity is formed through association with these civil 
institutions which serve to control individual desires and impulses.  Coalitions, rather 
than class consciousness, reflect how individuals make sense of their own lives based on 
shared beliefs, values, and commitments.  Similar to Foucault’s “expert eyes,” Gramsci’s 
concept of hegemony is political power that flows from intellectual and moral leadership 
to build consensus, which is a move away from physical control over the body to 
conformity through the individual’s willing participation.  “Articulation” is the political 
process by which individuals redefine their identities, which are not static but fluid and 
constantly changing.  Individuals often choose to participate because “experts” deem 
certain actions to be in the individual’s best interest.  Additionally, the knowledge of 
  6 
 
experts informs social policy which becomes the predominant course of action (Seidman 
2004). 
A third theoretical position that is applicable to the PPD issue is critical 
constructionism, a synthesis of conflict theory and social constructionism that focuses on 
how the meanings of social problems are constructed.  Critical constructionism maintains 
that elite interests determine which phenomena are problematic; provide explanations for 
the causes of the phenomena; and persuade the public that the phenomena are 
problematic and, therefore, require action (Heiner 2002:9).  Influenced by corporate 
sponsorship and driven by profits, the media serve as vehicles for influencing public 
opinion.  By reporting on social problems caused by the less powerful but deflecting 
reports which implicate wrongdoing by their corporate sponsors, the media participate in 
shaping public response to social problems.  Critical constructionism recognizes an 
imbalance of power between the elite and those with the least amount of power in 
society.  From this theoretical perspective, those in power exert their influence to 
maintain the status quo, allowing their continued dominance.    
Postmodern feminism, which seeks not only to include women in research but to 
deconstruct hierarchically informed knowledge and power (Hesse-Biber and Yaiser, 
2004), is also relevant to my topic.  Postmodern feminism is concerned with giving 
women the same rights as men, but recognizes that race, class, ethnicity, gender, and 
sexuality intersect to create multiple consciousness and to affect social structure.  The 
intent of postmodern feminism is to create resistance to the status quo and interrupt 
power-knowledge relations: 
Postmodern feminists often use texts (in varied forms), the products of 
dominant culture and signs of postmodernity, in conjunction with the view  
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of the oppressed, as the starting point of cultural interrogation…not in order to 
reconstruct another view of the social world (an exercise in power and 
colonization) but rather to unravel the social processes and relations that have 
constructed the social world in hierarchical ways. (Hesse-Biber and Yaiser 
2004:19) 
 
 
 
METHODOLOGY 
 For this study I conduct a multiple method content analysis of literature on PPD 
from two on-line sources, Medline and LexisNexis.  The purpose of the study is to 
determine how PPD is framed by the medical community and how it is represented in 
medical literature compared to general news.  I use simple descriptive statistics to 
illustrate its movement to the medical model, including the most common causes, effects, 
and recommended treatments.  For the qualitative analysis, I examine the discursive 
elements shaping PPD as a disease by noting the authors’ descriptions of PPD, of 
motherhood, and of the role of medical professionals.  The importance that language 
plays in social life is the basis of the qualitative analysis, and the articles serve as 
narratives from which one can understand how the medical profession frames the issue of 
PPD.  My intent is to examine the scope of discourse on PPD, noting the most common 
themes as well as those that are infrequent but informative indicators of PPD in medical 
and non-medical contexts, revealing ranges and patterns of defining PPD.   
 For example, in my notes several of the authors mention the need to screen 
mothers for depression beyond the traditional 6-week postnatal checkup because of the 
possibility that depression can occur later, and others suggest that depression may begin 
in pregnancy and suggest that screening begin before delivery.  Combining the 
information on the prescribed periods of screening exposes the range and pattern 
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recommended by the authors and brings the realization that the postpartum period is 
being redefined as a longer timeline, extending to three months, six months, one year, 
two years, five years beyond delivery, as well as extending back into pregnancy.  This 
finding adds depth to our understanding of medical control over the procreative process 
and its effect on women’s lives, a finding that would have been missed with the 
quantitative study alone.   
 
Data Collection 
There are over 700 articles on PPD on Medline to date and, as previously noted, 
to keep the analysis manageable I select a sample from the articles in five year 
increments, starting with 2005 and proceeding back to 2000, then 1995, 1990, 1985, 
1980, and 1950.  There are no articles between 1980 and 1950, and the bulk of the 
Medline articles were printed in 1995, 2000 and 2005.  After eliminating articles that 
were only available in a language other than English, as well as one article that had been 
withdrawn from publication, I chose to keep all of the articles from 1950 (1), 1980 (2), 
1985 (2), and 1990 (14) in my sample.  Medline has a total of 22 articles on PPD 
published in 1995, and 27 in 2000, of which I eliminate every third article so that a total 
of 14 articles represent the year 1995 and 18 articles represent the year 2000.  In 2005, a 
total of 87 articles were published in Medline, and I select every fourth article for 
inclusion for a total of 18 articles from 2005.  Thus, the total number of Medline articles 
on PPD in my sample is 69, and the number representing each year of my study is fairly 
even.   
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In addition to the Medline articles, there are 127 articles on PPD (as of November 
2006) in the general news section of major newspapers in the LexisNexis database for the 
same years as the Medline articles.  The bulk of the LexisNexis articles were printed in 
2005, most centering around the disagreement between Brooke Shields and Tom Cruise 
over the legitimacy of PPD.   Again, I keep all of the articles from 1980 (2), and 1990 (1) 
(there were no articles printed in 1985), but select a stratified random sample from the 12 
articles printed in 1995, the 31 articles printed in 2000, and the 81 articles printed in 
2005.  For 1995, I eliminate every third article; for 2000 and 2005 I include the first 
articles and every fourth article thereafter.  The total number of LexisNexis articles is 40, 
bringing the total number of articles in my sample from both databases to 109.  
Examining the articles in five year increments allows an analysis of changes in frequency 
and representations over time. 
 
Coding 
To facilitate coding for the quantitative portion of this study, I devised a code 
sheet (Appendix A) with nine sections.  Section 1 includes identification of the article by 
number, database, and year published.  Section 2 includes information on the author, 
including name, gender, and credentials (MD, PhD, PsyD, RN, LPN, LCSW, LPC, and 
others).  It also includes sponsorship of the article, such as pharmaceutical company, 
medical practice, or professional organization, if available.   
Section 3 references the etiological definitions of PPD, including its causes: 
biology (hormones, sleep deprivation, diet, and others), psychology (prior depression, 
coping skills, perfectionism, low self-esteem, childhood experience), and social (family 
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support, marital relationship, friends).  Section 4 examines whether the article implicitly 
or explicitly infers that some groups are more vulnerable or at risk for experiencing PPD 
because of biographical characteristics (age, marital status, class, race, or ethnicity).   
Section 5 codes for symptoms of PPD, including physical (insomnia, no 
energy/fatigue, appetite changes, headaches, chest pains, heart palpitations, 
hyperventilating); emotional (anxiety, excessive worry, confusion, sadness, feeling 
overwhelmed, feeling inadequate as a parent, incoherence, feeling of hopelessness, 
thoughts of suicide, hallucinations); or behavioral (crying, oversensitivity, irritability, 
panic attacks, hostility, paranoia).  Section 6 examines the intensity (baby blues, PPD, or 
postpartum psychosis) and prevalence (in terms of percent of new mothers who have 
baby blues, PPD, or postpartum psychosis), and whether the article suggests that others 
can have PPD (fathers, other family members, friends).  Vulnerability of fathers and other 
family members would implicate social rather than biological causes.   
Section 7 codes for suggested treatments for PPD, including medication, 
counseling, social support, or a combination of the above.  Section 8 codes whether the 
article uses fear to promote PPD as a disease by mentioning consequences of PPD (harm 
to child, harm to mother, harm to spouse, harm to family, harm to society), and whether it 
mentions extreme cases of PPD such as Yates.  And Section 9 codes for whether the 
article advocates proactive intervention of medical professionals through screening (of 
new mothers, new fathers), educating (mothers, fathers, health care professionals), or 
supporting (new mothers, new fathers, or health care professionals).  The final section 
allows for comments or quotes that inform the qualitative analysis of the articles.   
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Test-Retest of Reliability 
 For this analysis I draw upon coding categories that were reasonably clear cut and 
I strove to make the coding categories as concrete as possible to increase coding 
reliability; thus no additional coders were necessary.  Some time after I completed 
coding, I selected one out of every 20 articles to check the test-retest reliability of the 
coding process, recoding a total of five articles.  By making the coding categories as 
concrete as possible, I minimized (but not eliminated) the threat to reliability; the answers 
on the recoded articles were very consistent at an average of 98 percent.   
 
Limitations of the Study 
 Perhaps because of commercial reasons, LexisNexis adds articles to its database, 
not because new articles are written as time goes by but rather articles from the same 
historical time period are added at later dates.  Methodological implications include that 
the study would be difficult to replicate, as a researcher who today searches in 
LexisNexis for articles on postpartum depression in the general news section of major 
newspapers would find vastly larger sets of text than those included in my sample.  Also, 
the few articles written before 1990, although extremely helpful in revealing the 
increasing focus on PPD, provide few cases from which to compare percentages (e.g., of 
authors who recommend social support as treatment) to later articles.  For instance, 50 
percent of articles in my sample from 1980 include two out of four, whereas 50 percent 
of articles in 2005 include 19 out of 38.  Therefore, although the percentages are the 
same, many more authors are in agreement in their representations of PPD in the later 
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years.  Despite these limitations, I think these materials provide rich textual sources for 
understanding the medicalization of postpartum depression.   
 
 
CHAPTER 2 
LITERATURE REVIEW 
Murphy-Lawless (1998) chronicles the movement of childbirth into the medical 
model, in which medical intervention and obstetrical practices came to be accepted as the 
norm. The male-dominated field of obstetrics offered empirical, scientific knowledge of 
the childbirth process which gradually replaced women’s experiential knowledge.  The 
risk of complications and/or death of the child or mother became the impetus for 
surrendering agency over to medical experts in the birthing process (Murphy-Lawless 
1998).  Further, Murphy-Lawless asserts that the firm entrenchment of scientific 
“evidence” and the authority of the medical profession make it difficult to reclaim agency 
in the birthing process.  She finds that the sociological struggle between the patriarchal 
male as hero and the (presumed) physically and intellectually incapable woman is clearly 
visible in the childbirth arena, which delineates the concept of knowledge as power, 
dominance by the knowing individuals (obstetricians), and subjugation of women in 
childbirth.   
Similarly, Goer (1999) echoes the view that obstetrics empowers the mostly male-
dominated field of experts while it discounts women’s knowledge, intuition, experience, 
and role in the birth process.  Goer states:  
The typical obstetrician is trained to view pregnant and laboring women as a 
series of potential problems, despite the fact that pregnancy and childbirth are 
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normal physiological processes that are no more likely to go seriously wrong 
than, say, digestion. (Goer 1999: 3)   
 
Both Goer and Murphy-Lawless reject the obstetrical belief that women’s bodies are 
weak and need the obstetrician’s medical intervention to rescue the baby from the 
mother’s body.  They posit that although scientific claims to objectivity and expert 
knowledge and practices are illusions, individuals nevertheless surrender agency to the 
experts in charge of medical care because of the legitimacy accorded to science.   
A body of literature suggests that the subjugation of women continues in 
motherhood, beginning during pregnancy when many social controls are placed on the 
pregnant woman.  Through the discourse of endangerment, the period of pregnancy is 
structured as part of the extended timeline of childhood, removing the focus from the 
woman and placing it on the developing fetus (Rothman 1982; Brooks Gardner 1994).  
The perception of childhood beginning before birth expands the mental construct of when 
life begins, setting temporal boundaries (Zerubavel 1991) that have profound political 
implications such as a tension between rights of the “fetus-infant” and the reproductive 
rights of the woman (Isaacson 1996: 472).  The rhetoric of endangerment places sole 
responsibility on the woman to gain expert knowledge and to act responsibly so that a 
healthy infant results from the pregnancy (Rothman 1982; Brooks Gardner 1994:72).  
Socialization, through both medical experts and popular sources, obligates the pregnant 
woman to regard the fetus’s health as more important than her own and to center every 
action, thought, and ingestion on giving the fetus every possible chance for optimum 
development.   
 In the United States, a woman’s behavior during pregnancy becomes subject to 
 many measures of control that emphasize the indirect consequences of her 
 actions, thoughts, and feelings on the malleable fetus, which requires the 
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pregnant woman to self-impose restraints for the future good of the child. (Brooks 
Gardner 1994:71) 
 
Some literature suggests the medicalization of women’s emotionality, resulting in 
greater numbers of women diagnosed with depression.  Stoppard (2000) asserts that 
women more often than men are socialized to use coping strategies such as forbearance 
and negotiation, which are often characterized as passive, problem-avoidant, emotion-
focused, and viewed as deficits.   The androcentric focus of psychiatric norms places 
women at greater risk for “atypical depressions” that include anxiety/depression 
syndrome rather than the DSM-IV specified symptoms of Major Depressive Disorder 
which typify mostly men with depression (Stoppard 2000).   
Similarly, Shields (2002), in a study of stereotypical gender differences in 
emotionality, posits that women’s emotional expressions are often connected with 
weakness, making women more vulnerable to the dominance of medical experts. 
Bilirakis (2004) adds a biological root to depression, suggesting that hormonal factors 
contribute to the increased rate of depression among women, which is approximately 
twice the rate of depression among men.  Stoppard and McMullen (2003) and Mauthner 
(2002) implicate social reasons for the increased rate of depression among women, 
arguing that women’s depression is caused by cultural proscriptions about the “good 
mother” which prevent women from expressing any negative feelings about mothering.  
Others support this ideological argument, suggesting that discourse surrounding 
motherhood bolsters cultural expectations that having a baby should be a happy time in a 
woman’s life (Kaur 2004; Meltz 2003; Smith 2004).  Depression results because the 
reality of motherhood often contrasts sharply with idealized constructions of motherhood 
(Mauthner 2002).   
  15 
 
Mothers themselves, anxious to live a Gerber commercial, may feel ashamed  
or guilty about having any negative thoughts. . . . Antidotes for postpartum  
depression begin with an awareness of symptoms: excessive worry about  
caring for the baby; teariness; anxiety or panic; inability to sleep when the baby 
sleeps; difficulty doing regular tasks; inability to take pleasure in the baby. (Meltz 
2003)  
 
Greater publicity around sensationalized cases, such as that of Yates, increases 
public awareness and concern and results in increasing numbers of women identifying 
with the symptoms as suggested by the experts.  The news of “normal mothers” killing 
their children contributes to the fear that untreated PPD can lead to postpartum psychosis 
(Kaur 2004) and have a tragic end.  PPD prevention programs are then established to 
train health care workers to identify women with PPD and get them into treatment (Smith 
2004).  Hubert (2002) suggests the result is that more women willingly collude in their 
own gender-biased diagnoses.   
 
Defining Postpartum Depression 
PPD is not a new phenomenon: Hippocrates described emotional difficulties of 
the postpartum period thousands of years ago; in the mid-19th century, studies again 
highlighted psychotic episodes but did not label PPD a separate illness (Kruckman and 
Smith 2000).  Nor is PPD a condition unique to western cultures (Dennis 2004), as 
research shows PPD is reported to exist in a wide array of countries – among them 
France, India, Turkey, Mexico, Cambodia, Brazil, Germany, Taiwan, China, 
Czechoslovakia, Canada, Turkey, Malta, Sweden, and Korea.    
In the United States today, the medical community does not label PPD a distinct 
disease but views it as an affective disorder with characteristics similar to general 
depression occurring in the postpartum period, generally six weeks following delivery 
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(Kruckman and Smith 2000).  Although the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) II listed PPD as a separate illness during the 1960’s, it eliminated the 
category in 1980, stating that there was not enough evidence to consider it a distinct 
disease (Kruckman and Smith 2000). 
Weitz (2004) suggests that the DSM is problematic in that it often politicizes 
diseases.  She claims that although the DSM provides standardized diagnostic criteria for 
mental illnesses, clinicians are often biased when applying them to female and/or 
minority patients.  A panel of experts decides what is considered a disease, which often 
reflects historically-situated norms and values.  For example, the DSM listed 
homosexuality as a disease in the DSM until 1973, reflecting cultural values of that 
period (Ford and Widiger 1989).  A result of this method of disease classification is that 
more African Americans than whites are diagnosed as paranoid schizophrenics with 
violent tendencies, and more women than men are diagnosed as having depression and 
histrionic personality disorder (Weitz 2004).   
The Mayo Clinic Complete Book of Pregnancy and Baby’s First Year (Johnson 
1994), available in the birth and pregnancy section of national bookstore chains, 
categorizes PPD as an illness of the brain, which is susceptible to illness just like other 
organs in the body (Johnson 1994:426).  In addition to describing the sudden change in 
hormones that occurs postpartum, the Mayo Clinic book, edited by a physician, lists 
social factors which may contribute to PPD, including disappointment at not having the 
mythical “perfect birth;” a response to postpartum pain or discomfort; a letdown from an 
exciting event; concerns about dealing with the new baby; or surprise about the amount 
of work involved in caring for the baby (Johnson 1994).   
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Similarly, The National Women’s Health Information Center (2002) describes 
PPD as “… a range of physical and emotional changes that many mothers can have after 
having a baby.”  It separates PPD into three distinct categories: the “baby blues,” which 
occurs soon after childbirth and continues for one to two weeks; postpartum depression, 
which starts anywhere from soon after to even a few months after childbirth and 
continues for as long as one year; and postpartum psychosis, an extreme form of PPD 
which usually begins within three months after childbirth.  According to current medical 
wisdom, the baby blues affect an estimated 50-80 percent of all new mothers, postpartum 
depression affects between 3-20 percent, and postpartum psychosis affects approximately 
.1 percent (or 1 per 1000 births) (Kruckman and Smith 2000).   
Organizations such as Postpartum Support International (PSI) and Postpartum 
Education for Parents (PEP) provide information about the malady as well as resources 
for parents seeking assistance.  They are often headed by medical doctors, psychiatrists, 
Ph.D.s, and other experts, and encourage professional medical help for the mother as well 
as support from family, friends, and support groups.  They express the belief that the 
disorder is caused by a combination of physical and social factors, specifically hormone 
changes which affect brain chemistry and social stresses such as poor partner support and 
social isolation.  Consequently, emotional, social, and physical support are the 
recommended remedies.  The PEP website states:  
Our society does not currently accept brain disease as it accepts physical  
illness.  There is a stigma about depressive disorders.  The illness is difficult  
to explain. Those closest to a depressed mother need to understand that while 
psychological and environmental stress may play a role, depression is basically 
a physical and chemical disorder.  Give support, encouragement and hope.  Your 
assistance during this time of crisis is invaluable. (Logan 1989) 
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Thus, the PEP website iterates a common bid for legitimacy, presenting PPD as a real 
disorder with physical and social causes, and not “just in her head.”    
PSI offers an anthropological approach to its analysis of PPD, stating that the 
postpartum period in the United States is informally structured as compared to non-
Western, rural cultures in which extended families provide support during the postpartum 
period.  PSI characterizes the postpartum period in the United States as emotionally 
draining, stressful and fatiguing; the baby blues and mid-levels of depression result from 
modern birthing practices, the lack of clear role definition, and the lack of social support 
for the new mother (Kruckman and Smith 2000).  However, PPD is not unique to 
Western culture, but is found in many non-Western countries as well. 
The New Well Pregnancy Book (Samuels and Samuels 1996), a self-help book, 
surmises that PPD results from feelings surrounding the birth process.  Some mothers 
expressed missing having the baby inside, as what once seemed to be a part of them was 
not anymore; some found that with delivery the focus of attention shifted from them to 
their babies.  Other mothers reported feeling they were at fault for not having performed 
better during childbirth, or felt that the hospital or staff cheated them out of the kind of 
delivery they were expecting (Samuels and Samuels 1996).  Another self-help book, 
Conception, Pregnancy and Birth (Stoppard 2000) surmises that the sudden change in 
hormone levels, personal or relationship problems, severe exhaustion, and the lack of 
potassium, can lead to PPD.  The book recommends such self-help strategies as rest, 
proper diet, gentle exercise, and talking over feelings with others – especially one’s 
partner – as remedies for PPD.  In addition, psychiatric help, which includes 
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antidepressants and mild sleeping pills, assists in recovery, according to the author 
(Stoppard 2000). Medication is endorsed even when alternatives are given. 
 
Symptoms and Treatment for PPD 
According to Kruckman and Smith (2000), symptoms fall into physical, 
emotional, and behavioral categories and vary by severity of PPD.  Symptoms of the 
baby blues are mild and last a few days to a few weeks, whereas postpartum depression is 
marked by longer periods of depression.  Physical symptoms range from lack of sleep, no 
energy, and appetite changes to headaches, chest pains, heart palpitations, and 
hyperventilating.  Emotional symptoms run the gamut from anxiety and excessive worry, 
confusion, sadness, and feeling overwhelmed or inadequate as a parent to hopelessness, 
thoughts of suicide, bizarre hallucinations and incoherence.  Behavioral symptoms range 
from crying, oversensitivity, and irritability to panic attacks, hostility, and paranoia.  
Postpartum psychosis is the most severe, with symptoms that may include extreme 
confusion, loss of memory, inability to function, and possible harm to infant or self 
(Kruckman and Smith 2000).    
Treatment options vary widely and include psychiatric intervention, 
psychotherapy, cognitive-behavioral therapy, antidepressants, antenatal classes, 
relaxation techniques, educational strategies, social support during the postpartum period, 
and more (Kruckman and Smith 2000).  However, the efficacy of these approaches is 
difficult to determine due to research design flaws, specifically small sample size and 
exclusive sampling, that fail to determine the outcomes of such interventions (Dennis 
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2004).  Estimates of the prevalence of PPD vary due to unstandardized reporting 
practices as well as to the vagueness in defining PPD.   
 
 
PPD and Legislation   
Legislation plays into the issue in several distinct ways.  First, postpartum 
depression is used as an insanity defense for some cases in which mothers harm or kill 
their children.  As mentioned in Chapter 1, Andrea Yates’ attorneys successfully 
employed this defense, saving her from the death penalty and sending her to prison for 
life (Colb 2003).  The jury had to decide between two possibilities in determining her 
fate: either Yates was a good mother who experienced temporary insanity, or Yates was 
an evil monster who murdered her children (Colb 2003).  Colb asserts that the insanity 
defense could not spare her a life sentence because to accept her actions as a lapse from 
sanity would shatter a benevolent view of motherhood, allowing the possibility that other 
mothers could commit similar atrocities.  Therefore, the jury convicted her out of the 
need to hold her accountable and to keep other mothers from similar actions (Colb 2003).     
In the Yates case, it is rarely disclosed that multiple factors converged that 
resulted in the tragic deaths.  Yates was treated for schizophrenia and depression after the 
birth of her first child, and re-diagnosed after the birth of her fourth child.  She, her 
husband, and four small children lived in a cramped bus converted into a living space, but 
shortly before the birth of their fifth child moved into a more spacious home.  In addition, 
she was influenced by religious fanaticism that led her to believe she was a bad mother 
and that her children would be spared an eternity in hell if she murdered them.  And her 
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physician warned her husband and her after the birth of their fourth child that an 
additional pregnancy could result in renewed mental problems; yet the responsibility of 
caring for five young children after the birth of the fifth child fell solely on her.  In 
retrospect, Yates’ husband said the family knew of her illness but thought she was doing 
well.  They never suspected that she would kill her children (Couric and Morales 2005).   
Legislation also enters into the PPD issue with the proposal of at least two bills, 
not yet passed, to address PPD.  The Melanie Blocker-Stokes Postpartum Depression 
Research and Care Act (H.R. 846), introduced in February 2003 and referred to the 
House subcommittee on Health later that same month, proposes mandated screening for 
PPD.  Its author, self-professed women’s health advocate Rep. Bobby L. Rush, D-IL, 
states: “It’s time for us to recognize postpartum depression for what it is – a mental health 
condition that requires medical treatment, not jail time” (Harris 2005).  Rush states that 
the overturn of Yates’ murder conviction in 2005 leads to a better understanding of 
postpartum depression by the public as well as law enforcement officials, and that the bill 
would help erase the stigma associated with PPD by recognizing it as a true illness 
(Harris 2005).  A second bill, House Bill 1427, introduced in the January 2005 Regular 
Session and reintroduced in the January 2006 Regular Session, seeks funding for an 
outreach campaign to educate people about PPD (Cook 2005).  The sponsor of the bill, 
Rep. Mary Helen Roberts, D-WA, said the bill would legitimate the condition as a 
disease and remove the image of PPD that is the focus of jokes about “raging hormones” 
(Cook 2005).   
Even though it’s common and very treatable, many women don’t know  
about postpartum depression and are afraid to seek help. The stigma of  
mental illness hits doubly hard for women who are struggling with sadness  
at a time when everyone expects them to be thrilled with their new baby. (Cook  
2005)   
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Impact of PPD on Family 
Perhaps the most compelling argument used to garner support for its 
medicalization is that PPD affects the family – the infant, the spouse, and older siblings.  
Some studies claim that children with depressed mothers may exhibit long-term deficits 
that affect the child beyond infancy to school age, such as inhibited speech development 
and a weak mother-child relationship, due to the mother’s failure to interact with the 
infant (Meltz 2003; Puckering 2005; Toneguzzi 2004).   A Scottish study which provided 
adult mental health services for new mothers found that deficits relating to the weakened 
mother-child bond persist beyond when the mother’s depression ends (Puckering 2005).  
In Barbados, researchers found that maternal depression, along with reduced infant 
lengths and weights at 7 weeks, 3 months, and 6 months postpartum, were predictive of 
lower scores on the Common Entrance Examination (CEE) for entry into high school, at 
ages 11 to 12 years (Galler et al. 2004).  A contrasting study found that cognitive 
problems in the 4-year old children of depressed mothers showed no lingering effects 
from PPD at the 7-year level, although the children were affected by such conditions as 
low SES (Kurstjens and Wolke 2001), which typically is not treated.   
Some literature on PPD finds that fathers can also experience PPD resulting from 
additional stresses such as the mother’s depression, having an unsupportive relationship, 
or being unemployed (Ballard and Davies 1996).  Kleiman (2006) finds that 62 percent of 
fathers suffer from the baby blues some time during the first four months following birth, 
and 10 percent suffer from PPD.  Paulson (2006), in his Early Childhood Longitudinal 
Study involving 5,089 two-parent families, also asserts that approximately 10 percent of 
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new fathers suffer from PPD, causing decreased interaction between father and infant 
with implications for future development of the child.  The deterioration of intimacy due 
to lack of communication about the stresses of a new baby causes postpartum depression 
in fathers, and 25 percent of all couples end their marriages within five years of having a 
child (Parks 2005).  Some symptoms of PPD in fathers include dramatic weight gain or 
loss, difficulty sleeping, sadness, loss of interest in normal activities or hobbies, and 
difficulty making decisions, due to the shift to parenthood (Smyth 2003).  The finding 
that fathers can experience PPD may rule out biological factors, such as hormones, as the 
cause of PPD and place more emphasis on social or structural factors (Kleiman 2006).  A 
brief look at sociological literature finds no resistance to the concept that fathers can also 
have PPD.     
Currently, depression rating scales used for diagnosing PPD include the Hamilton 
Rating Scale for Depression, the Edinburgh Postnatal Depression Scale (EPDS) (see 
Appendix B), which are both used for detecting general depression, and the Beck 
Depression Inventory (BDI) (see Appendix C), among others.  The depression surveys 
are administered by a health professional or may be completed by the patient, and higher 
scores indicate higher levels of depression.   
 
Feminism and PPD 
Some feminist authors theorize that PPD is caused by such social factors as 
isolation, severe stress, lack of partner support, and changing roles due to parenthood.  
According to Taylor (1996), the dominant discourse surrounding PPD overlooks the 
social construction of gender order as it expresses an essentialist belief in biological 
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differences between women and men, resulting in conventional gendered power 
dynamics.   
As a structure, gender divides work in the home and in the wider  
economy, legitimates existing hierarchies of authority, organizes sexual  
expression and emotions, and structures every aspect of our lives because 
of its embeddedness in the family, the work place, the state, as well as in sexuality, 
language, and culture. (Taylor 1996:14) 
 
Taylor stresses the role that media play in furthering discourse blaming mothers for all of 
the ills of society and in echoing current political conservatism that calls for a return to 
traditional family values.  “Mothers, traditionally revered in the public discourse, are now 
being portrayed as much more complex, even wicked, beings” (Taylor 1996:4).  The 
changing roles of women result in questions surrounding “appropriate” behavior 
regarding such contemporary issues as working mothers, lesbian motherhood, single 
motherhood, abortion and birth control rights, and the choice of self-identity outside of 
motherhood.  Taylor further asserts that the structure of families in modern society 
creates problems of isolation and alienation. Support groups that arise in varied contexts 
illustrate the impersonal quality of relationships, further complicated by the loss of close 
extended family ties. 
Modern social life is regulated more and more by the highly specialized,  
technical, and impersonal knowledges of science, medicine, mental health,  
the law, and other expert systems. These systems transmit technical knowledge 
that influences how we experience almost every aspect of our lives – the  
illnesses we suffer, the foods we eat, the medicines we take, the emotions  
we express, our recreational habits, even how we experience sexual desire.  
In modern self-help groups, people find a special space where they can develop 
their own explanations of, and solutions to problems based, at least in part, on 
everyday experience. (Taylor 1996:19)   
 
Taylor (1996) finds that PPD support groups represent collective action for 
redefining gender relations, a struggle to reflect disadvantages of gender through shared 
experiences common in everyday life.  Whereas obstetrical practices focus on biological 
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aspects of motherhood and replace women’s experiential knowledge with scientific 
knowledge, Taylor asserts that support groups empower women to resist traditional 
ideologies of motherhood by allowing them to share their experiences of motherhood, to 
build solidarity with other women, and to question traditional gender relationships within 
the family.  Such collective action represents “the renegotiation of motherhood taking 
place through the discussion of postpartum illness” (Taylor 1996:11).   
When women express their negative feelings, they experience themselves  
as different from traditional – and ideal – mothers. Solidarity with other  
women and the group consciousness that grows out of participation in  
self-help makes it possible, however, for women to use cherished ideals  
about motherhood for their own purposes ‘…to replace the myth of maternal  
bliss with a more inclusive view of motherhood’ that is ‘more realistic and  
accurate’ and places more emphasis on ‘the challenges and difficulties that  
are part of the territory’ (Taylor 1996:142). 
 
  
Taylor advocates forming support groups for PPD in order to force the medical 
establishment to recognize PPD as a separate disease (Taylor 1996:154), which would 
offer the advantages of lenient legal defense for mothers who injure themselves or their 
babies as a result of PPD, insurance coverage for treatment, education projects for the 
public on PPD, training for health professionals to recognize and treat PPD, and funding 
for research on treatment and prevention (Taylor 1996:156).  Additionally, support 
groups would allow women’s experiential knowledge of birth and motherhood to counter 
the ideological representations of motherhood that confine women to idealized versions 
that often differ dramatically from reality.   
 
Complicity of Drug Companies 
Drug companies are business enterprises, requiring constant expansion of their 
markets through innovation in product and marketing (Engler 2003; Diller 2005; Thomas 
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2004; Johnston 2004).  Their profitability relies on tweaking existing medications to form 
“new drugs,” on expanding disease categories (for example, generalized depression to 
include childhood depression and postpartum depression), and on marketing their 
products to medical professionals and to the public (Angell 2004).  The amount that drug 
companies spend on direct-to-consumer advertisement more than tripled between 1996 
and 2001, amounting to about $2.7 billion in 2001, and today reaching approximately $4 
billion annually (Rowe 2006; Vendantam and Kaufman 2005).  Dr. Lisa Schwartz 
remarks on the results of drug advertising: “We’re increasingly turning normal people 
into patients.  The ordinary experiences of life become a diagnosis, which makes healthy 
people feel like they’re sick” (Rowe 2006).  Advertising drugs brings medical problems 
to the individual level, medicalizing problems that once fell outside of the medical 
domain and offering medication as a “quick but ultimately patient-centered fix” (Tone 
and Watkins 2007: 7).  Individuals pressure doctors to prescribe the advertised drugs, to 
the extent that the typical American had 12 prescriptions a year by 2004, up from seven 
prescriptions a year in 1994 (Rowe 2006).   
Perhaps the worst part is that prescription drug ads have immersed us all in 
a pervasive drug culture that seems to have no boundaries. We are being 
reduced to helpless “consumers” who have no capacity to deal with challenges 
other than by taking a pill (Rowe 2006: 9).    
  
Drug companies control academic medical research through contracts with 
academic institutions, and they receive government sponsorship of research projects, 
resulting in research bias that removes the objectivity of scientific research and endangers 
the health of consumers (Angell 2004; Krimsky 2003).  Additionally, drug companies 
benefit from monopoly rights that include patent protection and tax breaks for research 
and development expenses.   
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In his book, Let Them Eat Prozac: The Unhealthy Relationship between the 
Pharmaceutical Industry and Depression (2004), psychiatrist David Healy maintains that 
depression replaced nervousness, the psychiatric illness prevalent during the first eight 
decades of the twentieth century.  Tranquilizers were the preferred treatment for “nerves” 
and were available over-the-counter or through prescriptions, making them widely 
available to large numbers of individuals regardless of their socioeconomic status.  
Although the use of tranquilizers began to wane in the 1970’s, it primed the population 
for accepting psychotropic drugs to treat emotional symptoms.  Healy states that 
depression was rarely heard of prior to the development of Prozac; in order to market 
antidepressants the pharmaceutical companies had to also market depression as a 
treatable illness (Healy 2004).  SSRIs replaced tranquilizers as the preferred treatment for 
the new disease, depression. 
Diller (2005) questions the practices of American psychiatrists in what he calls a 
“drug culture,” the dramatic change toward medicating disorders such as depression and 
hyperactivity which began in the early 1990’s.  He finds that 9 out of 10 children under 
the care of American psychiatrists are on one or more psychiatric drugs, whereas 
European physicians and psychiatrists rely more heavily on other treatments (Diller 2005: 
28).  Although his study focuses on children’s health, he finds that drug companies 
influence medical professionals by funding national physicians’ conferences, by offering 
free samples of high-priced medications, by wooing physicians with free dinners and 
consultant fees.  In addition, drug companies hire expert witnesses to affirm the efficacy 
and safety of their drugs, and they withhold findings which indicate ineffective, negative, 
or harmful effects.  Although drug companies are required to file negative reports with 
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the Food and Drug Administration (FDA), they are not required to publish or make 
public harmful outcomes.  Diller maintains that the profit-driven drug companies are 
most loyal to protecting the interests of their stockholders, even to the point of 
endangering their customers.   
 Similarly, Thomas (2004) exposes fraudulent marketing practices which drug 
companies use to gain profits, including suppressing research that contains negative data 
about their products.  In addition, she finds that drug companies promote drugs for off-
label use – that is, they encourage physicians to prescribe drugs approved for a specific 
ailment for many other ailments.  For example, she cites a study that found the makers of 
the drug Neurontin, approved for the treatment of epilepsy, paid doctors to prescribe it for 
manic depression, restless-leg syndrome, and other ailments.  The drug company hired 
ghostwriters to create articles promoting off-label uses of Neurontin and then paid 
honorariums of $1000 to doctors who lent their names as authors to the articles.  The 
company was sued when a patient diagnosed with bipolar disorder attempted suicide 
while taking Neurontin.  Thomas asserts that the influence of drug companies is 
enormous: the proportion of doctors to drug representatives is 2 to 1, and there is one 
drug company lobbyist for every member of Congress (Thomas 2004).   
 The general public believes that drugs are federally regulated and therefore safe 
for consumers once they are approved by the FDA.  However, a committee report by the 
Institute of Medicine, an affiliate of the National Academy of Sciences which advises 
Congress on public health issues, finds that the FDA has limited funds and authority to 
regulate licensed drugs once they are approved for consumer use (Nesmith 2006).  Such 
limitations weaken the FDA’s ability to protect and advance the public’s health, and fail 
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to hold drug companies accountable for the safety of their products. The report criticizes 
the use of fees paid by pharmaceutical companies to fund the FDA’s drug-approval 
process – authorized by the 1992 Prescription Drug User Fee Act – as a conflict of 
interest for the FDA which tilts the regulatory balance away from monitoring the safety 
of drugs once they are approved.  Further, the failure of the FDA to release negative 
reports about the safety of drugs raises concerns about “the extent to which the 
pharmaceutical industry has permeated the agency and how it may be influencing the 
agency’s policies, practices and regulatory actions” (Koski 2004: 24).   
 
CHAPTER 3 
FINDINGS 
Analysis of the articles from both databases reveals that the medical profession 
perceives postpartum depression as a national health priority (Logsdon et al. 2005), a 
significant public health problem whose incidence is second only to that of C-sections as 
a birth-related complication (Buchwald 1980; Horowitz et al. 1995; Kirkey 1995; Forman 
et al. 2000).  The authors describe PPD as a well-known clinical phenomenon that has 
always existed (Roland 1950; Unterman, Posner, and Williams 1990; Forman et al. 
2000), a highly prevalent disorder (Nonacs et al. 2005), the “thief that steals motherhood” 
(Goldbort 2005: 378) and takes the woman and her family by surprise (Beck and Gable 
2000).  It is one of the “darkest secrets of motherhood” (Kirkey 1995: C3), a “noteworthy 
health problem” (Gentile 2005: 945), a “living nightmare” of uncontrollable anxiety 
attacks, consuming guilt, obsessive thoughts and mood disturbance comparable to a 
major depressive episode (Beck 1995).   
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PPD is compared to other “dysfunctions” of women’s bodies such as menopause 
(Roland 1950), premenstrual syndrome (Stowe 1995), “pregnancy dysphoria” which 
includes postpartum blues and antepartum elements (Saks et al. 1985: 731), and 
“premenstrual dysphoria” or PMS (Pearlstein et al. 1990: 132).   Some “experts” believe 
PPD may be on the rise, resulting in “tears and fears,” and despair that grows deeper as 
time goes on (Bouchez 1995:7).  The postpartum period is considered a time-limited 
experience of enormous physiological and psychosocial adjustments and changes (Chen 
et al. 2000), one of the most critical phases of a woman’s life beginning one hour after 
delivery of the placenta (Gentile 2005).   
The articles in the LexisNexis database that are written by medical professionals 
or health reporters are similar in content to the Medline articles; however, there are three 
non-medical types of articles on PPD in LexisNexis that differ from Medline.  The first 
contains news articles that report on related events such as deaths attributable to PPD or 
proposed legislation.  The second consists of arts columns with celebrity gossip (such as 
the verbal exchange between Brooke Shields and Tom Cruise), art history (such as 
prehistoric art depicts PPD) or reviews of books, movies or plays about PPD (such as 
Shield’s autobiographical account of PPD, Down Came the Rain, or the movie Cotton 
Mary whose main character suffers PPD).  And the third has articles with metaphorical 
references to postpartum depression.  For instance, the term “postpartum depression” is 
used as an analogy in which a long-term project is compared to childbirth in two of the 
articles.  The feeling of euphoria that one author experienced at a project’s completion 
contradicts the presumed negative feeling that follows childbirth: “They say postpartum 
depression is supposed to be painful…this doesn’t feel like pain” (Siegel 1990: 69).  
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Similarly, Asimov (2005: F1) describes a feeling of despair which his subject felt at the 
completion of a project, growing and harvesting grapes for his winery: “As he stared at 
the cabernet sauvignon vines, which had just been harvested of grapes the day before, he 
said, a sense of sadness and loss came over him. ‘It was the weirdest feeling, like 
postpartum depression.’”  These references connote an image of marking time, a letdown 
occurring upon completion when the focus is no longer on the impending “birth” of the 
project and a new focus has not yet come into view.  The common use of the term in non-
medical sources indicates a general acceptance and understanding of the conditions 
inherent to PPD among non-medical populations.   
Non-medical discourse on postpartum depression brings more attention to the 
issue, creating both proponents and opponents of the claim that it is a mental illness.  For 
example, a LexisNexis article reports on a radio station in New Jersey that was censured 
after a disc jockey made flip on-air remarks about the postpartum depression that had 
afflicted the wife of N.J. Acting Gov. Richard J. Codey.  The author stated that the station 
“has a long history of plunging into polarizing political issues, and shows no signs of 
letting up” (Bruder 2005: 7).   
The polarity of discourse is evident in many of the 2005 articles in the LexisNexis 
database which refer to the debate between Tom Cruise and Brooke Shields over whether 
PPD is a mental illness.  Flagler (2005) cites the Cruise/Shields debate and suggests that 
PPD is a potentially life-threatening illness, not a weakness, that can impair a new 
mother’s ability to interact with her baby.  She asserts that if depression is viewed as a 
weakness, then women will not seek the help they need in fear that their baby may be 
taken from them, and that comments such as Cruise’s “feed more fuel into the fire of 
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denial” (Flagler 2005: C5).  Shields rebuts Cruise’s criticism of the use of 
antidepressants: “To suggest that I was wrong to take drugs to deal with my depression, 
and that instead I should have taken vitamins and exercised, shows an utter lack of 
understanding about postpartum depression and childbirth in general” (Bone 2005: G-8; 
Miller 2005: CO3).  Shields says she was overwhelmed by “feelings of doom,” and she 
asserts that once PPD is recognized as a serious medical condition, then treatment will 
become more available and socially acceptable (Bone 2005: G8).  Shields also counters 
Cruise’s attack on psychiatry, “It’s not the history of psychiatry, but it is my history, 
personal and real” (Miller 2005: CO3).   
In a review of Shields’ book on her experience with PPD, Neville (2005: G6) 
reveals that Sheilds discloses “so many truly aberrant emotions,” such as feeling jealousy, 
fear and rage when her husband held the baby while Shields was still on the operating 
table in serious condition.  The ideology of the good mother contrasts with reality as 
Shields states she was expected to bond immediately with the baby but instead felt such 
strong negative emotions; medication “pulled her back from the brink” when the feelings 
continued over time (Neville 2005: G-6).  Brody (2005: 7) also cites Shields’ book, 
stating that PPD is extremely treatable, beyond a mother’s control, and that drugs are 
“generally safe” even though they are excreted in breast milk and the effects are not well-
studied.  Grove and Morgan (2005: 24) side with Shields (“the star”) against Cruise (“the 
bit player”), sarcastically referencing Cruise’s vitamin cure for PPD: “Maybe the whole 
PR offensive will be a vitamin boost to his career.” An editorial in the Omaha World-
Herald also refutes Cruise’s rant against psychiatry, stating that PPD is a “very real 
concern for some women” and that “sophisticated drug research” has improved the lives 
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of mentally ill residents of Nebraska (Omaha World-Herald 2005).  Further, an article in 
The Tampa Tribune calls Cruise a “know-it-all actor” who came unglued; a “zealous 
practitioner of Scientology” who has no medical degree, a self-absorbed actor playing 
with people’s lives, a strange and angry man.  
 Fortunately not many people will give him much credence. The view that  
 modern medicine can be too quick to prescribe antidepressants is hardly  
 out of the mainstream. But science has long proved that certain drugs can  
 effectively treat mental illness. Postpartum depression, in particular, is  
 treatable (The Tampa Tribune 2005: 12).   
 
 
 
Expansion of Medical Control 
 We propose that thorough assessment of the mental health status of childbearing  
 Women is just as important as the many evaluations of biologic indicators of  
 health such as blood pressure readings, weight checks, and Papanicolaou smears  
 (Horowitz et al. 1995: 275).   
 
 
 The articles from both databases illustrate the expansion of the medical 
profession’s control over pregnancy, childbirth and mothering beyond the physical to 
include emotional and psychological aspects as well.  This expansion is visible in the 
increase in the number of articles published each year on postpartum depression (see 
Table 1).   The increase in frequency began before 1990, well before Andrea Yates 
murdered her children in 2001, which indicates that PPD became a phenomenon without 
a sensationalized introduction.  Only seven of the articles in the sample mention such 
sensationalized cases as Yates, although almost half suggest that PPD has dire 
consequences for the child, 40 percent suggest harm to the mother, and 25 percent 
suggest harm to the family.    
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Table 1: Frequency of articles on PPD in the Medline and LexisNexis Databases 
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The articles in the sample up to 1990 indicate that physicians recognized PPD in 
some of their patients and tried remedies such as injections of the hormone alpha 
estradiol, electroconvulsive shock therapy, or hospitalization, with the assumption that 
PPD has biological causes such as hormonal imbalances (Roland 1950) or thyroid 
malfunctions (Unterman et al.1990; Claman 1990)  Other articles implicate social causes 
of PPD, such as cultural expectations of motherhood that differ from reality (Beck 1995; 
Beck 1995; Berchtold and Burrough 1990; Feingold 1995; Beck and Gable 2000; 
Dankner et al. 2000; Leung, Martinson, and Arthur 2005; Goldbort 2005), body image 
issues that influence public perception of pregnant and postpartum women and lead to 
changes in their social lives, and the negative connotation of the term “housewife” 
(Tentoni and High 1980: 247); and new coping mechanisms that are required as roles, 
patterns, and relationships are renegotiated in parenthood (Gruen 1990).   
Before 1990, remedies such as social support for new mothers exceed the 
recommendation for counseling or medication: 43 percent (or three) of the seven articles 
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up to 1990 recommend social support, 29 percent (or two of the articles) recommend 
counseling, and 29 percent (or two of the articles) recommend medication (such as 
hormone injections) as remedies (see Table 2).  Practitioners offered  
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maternity/childbirth classes to dispel “myths” of pregnancy which women learned from 
other mothers, replacing experiential knowledge with “factual” knowledge (Tentoni and 
High 1980; Gruen 1990).  The 102 articles in both databases from 1990 through 2005 
recommend medication for the relief of symptoms more often (36 percent, or 36 of the 
102 articles) than social support (31 percent or 31 of the articles) or counseling (28 
percent or 28 of the articles).  Support groups sponsored by medical personnel offered 
women a chance to share their experiences with other mothers to discover that they are 
not alone in their struggle with the illness, to feel less crazy, to learn that other women 
get relief through the use of medication which is often necessary for recovery (Gruen 
1990).   
The articles in the total sample contend that the physical and emotional well-being 
of the mother is vital for the health of the whole family (Ugarriza 2000), and harm to the 
child is the most cited consequence of PPD:  48 percent (or 52 of the 109 articles in the 
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entire sample) indicate that PPD causes harm to the child (see Table 3).  Postpartum 
depression results in a woman minimally functioning in her role as mother,  
 
Table 3: Percentage of articles stating negative consequences of PPD 
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afflicting the mother/infant bond (Vandenbergh 1980).  The depressed mother’s 
interaction with the infant promotes less-than-optimal development, and signs of PPD are 
experienced as baby problems: “floppy helplessness, irritability, and feeding problems” 
(Schwarzbeck 1995: 3E).  Postpartum depression causes a mother to show little interest 
in her infant, to be less affectionate and more withdrawn or intrusive and hostile 
(Vandenbergh 1980), which interferes with the infant’s later well-being and predisposes 
him/her to increased risk of suffering from “socioemotional, cognitive, and psychiatric 
difficulties later in life” (Gentile 2005: 944).  Its negative effects continue through 
infancy into the teens and beyond.  Postpartum depression also affects the spousal 
relationship as women with PPD withdraw communication with their partner, have 
decreased libido due to fatigue and dyspareunia (painful intercourse), and therefore the 
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couple loses the “sexual expression of support” for each other in their transition to 
parenthood (Martell 1990:92).  Housework does not get done, babies become fussy, and 
the woman can become unattractive and run down by fatigue, causing the family sorrow, 
upheaval and disorganization (Martell 1990).   
Postpartum depression is labeled “the most consistent predictor of future negative 
parenting behaviors” including yelling, hitting, shaking (Halbreich 2005: 1317), and 
children of depressed mothers are at increased risk of accidents, sudden infant death 
syndrome, and higher frequency of hospital admissions (Forman et al. 2000).  Depressed 
mothers perceive their children as difficult, less adaptable to change, dependent and sober 
with negative emotionality; and children of depressed mothers are socialized to respond 
to mild stressors with anxiety (Whiffen 1990).  Postpartum depression produces a 
“compounded assault on the offspring’s physical and mental development and long-term 
vulnerability to disorders” (Halbreich 2005: 1319).   
The woman is subjectively portrayed in her role as mother, as solely responsible 
for the health and well-being of the whole family.  The mother is “burdened by an 
overriding demand on her ability to love,” to focus on her sense of incapability to love or 
to love sufficiently, while her spouse and other children “need reassurance they are still 
recipients of love” (Vandenbergh 1980: 1109).  Postpartum depression can incapacitate a 
woman to the point where she is unable to take care of the infant, and thus the family 
loses an “optimally functioning member;” by treating the mother, the entire family is 
supported (Martell 1990: 91).   
A woman’s relationship with her own mother is associated with vulnerability to 
PPD, thus conveying the importance of establishing a strong mother/infant bond (Saks et 
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al 1985; Trad 1995; Buist, Norman, and Dennerstein 1995).  Negative memories of her 
own experience with her caregiver may diminish a mother’s ability to form a positive 
relationship with the infant, in turn affecting the infant’s ability to form healthy 
relationships throughout life (Trad 1995).  An emphasis on a mother’s “interpersonal 
competence with the infant” suggests evaluating the mother’s interactions with the infant 
and her “intuitive” parenting skills: visual cuing (maintaining eye contact), vocal cuing 
(“baby talk” and verbalizing appropriate narrative), and holding behavior (firm yet gentle 
grasp, holding infant close to body while gently caressing and verbalizing with infant) 
(Trad 1995: 141).  A mother’s failure to competently and confidently care for her infant 
because of a poor role model or negative childhood experiences (such as childhood 
sexual abuse) may lead to neglect and abuse with consequences that last a lifetime (Buist 
and Barnett 1995).  The implication is that physical, cognitive, and psychological 
disorders are transferred from generation to generation through mothers, making PPD all 
the more threatening.    
To a lesser extent, the articles highlight the harm that PPD causes to the mother: 
41 percent of the articles from both databases (44 of the 109 articles) suggest that 
mothers suffer the effects of PPD.  Postpartum depression is consistently associated with 
the difficult transition to motherhood and the mother’s inability to adjust to her new role.  
The articles indicate that the transition to motherhood leads to erosion of self-esteem and 
feelings of inadequacy, possibly resulting from a sense of loss – of job or career, of 
freedom, spontaneity, identity (Tentoni and High 1980; Gruen 1990).  A new mother 
loses control over many aspects of her life – relationships, lifestyle, bodily functions, 
personal time (Stover and Marnejon 1995).  Roles, patterns, and relationships have to be 
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renegotiated, requiring new coping mechanisms (Gruen 1990).  The woman experiences 
a fear of her unfamiliar “state of self” and a lack of trust in her new role, feels she is a bad 
mother who does not love her child enough, and struggles with the responsibilities 
associated with being a wife and mother (Gruen 1990: 262).  Her quality of life is 
compromised because of the lack of positive emotions and interests, and she fears her life 
will never return to normal (Trad 1995; Beck and Gable 2000).  She suffers covertly, 
enveloped in loneliness, consuming guilt, and obsessive thoughts (Beck 1995). 
Just as medical professionals monitor the physical aspects of procreation from 
conception to the postpartum checkup in order to prevent malfunctions, the emotional 
and psychological aspects of childbirth are increasingly under medical control.  This 
expansion of the medical profession’s domain is visible in several areas of the postpartum 
depression phenomenon, including its timing and its ever-growing list of symptoms.  It is 
evident in the varied health care professionals who are being alerted to recognize its 
symptoms and implement the appropriate treatments, and in the development of new 
screening instruments and screening programs to more accurately and thoroughly 
diagnose PPD.   
 
 
Reconstructing the “Post” Part of Postpartum 
The DSM-IV defines PPD as “The presence of either depressed mood or 
decreased interest or pleasure occurring persistently for two weeks and resulting in a 
decline in functional status,” with onset occurring during the postpartum period, 
generally the first four or six weeks after delivery (Garg, Morton, and Heneghan 2005).   
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Childbirth is considered the “triggering effect” to PPD, and any emotional complaint 
after 10-14 days post-delivery should be considered abnormal (Stowe 1995: 640).  
However, many researchers suggest that monitoring should be extended to include longer 
postnatal periods, asserting that onset can occur later than suggested by the DSM-IV, 
such as within three months after delivery (Roland 1950; Blenning and Paladine 2005), 
up to six months after delivery (Garg et al. 2005; Stowe, Hostetter, and Newport 2005), 
or a full year after delivery (Stover and Marnejon 1995).  Handford (1985) finds that 
mothers are vulnerable to depression within three years after giving birth; similarly, Garg 
et al. (2005) find that many women with young children have symptoms of depression.  
Buist and Barnett (1995) posit that mothering does not end after the postpartum period, 
and Manfredi et al. (2005) suggest that not only childbearing mothers but grandmothers 
should be assessed for PPD.  The timeline for depression is gradually extended well 
beyond the postpartum period, with some articles intimating an indefinite period of 
vulnerability to PPD.   
Many of the articles support the extended timeline for the onset of postpartum 
depression.  When the postpartum period is narrowly defined, women with late onset 
depression are left undiagnosed, affecting prevalence rates that are much higher than 
generally reported (Forman et al. 2000).  Gruen (1990) asserts that PPD is rarely 
diagnosed even though it may affect up to 20 percent of families with new babies.  Beck 
and Gable (2000) find that up to 50 percent of new mothers with PPD are undiagnosed; 
similarly, Vandenbergh (1980) finds that up to 50 percent of new mothers may suffer 
PPD.  The importance of establishing an extended timeline for onset is that a delay in 
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diagnosis and treatment results in longer duration of PPD episodes (Beck and Gable 
2000) and a greater chance of recurrence (Trad 1995).   
In addition to extending the timeline beyond the initial postpartum period as 
described by the DSM-IV, many articles assert that onset occurs during pregnancy and 
continues in the postpartum period (Vandenbergh 1980; Stowe 1995; Forman et al. 2000; 
Goodnick et al. 2000; Glasser et al. 2000; Halbreich 2005; Carroll et al, 2005; Agoub, 
Moussaoui, and Battas 2005; Stowe et al. 2005; Wissart, Parshad, and Kulkarni 2005; 
Garg et al. 2005).  As many as 25-35 percent of women supposedly have depression 
during pregnancy (Goodnick et al. 2000), which increases the risk of PPD 2.5 to 4 times 
(Bloch et al. 2000).  Further, women with PPD are at a substantially increased risk for 
depression in subsequent pregnancies (Bloch et al. 2000).  A delay in diagnosis and 
treatment during pregnancy occurs because of several reasons: the symptoms of 
depression are often mistaken for normal conditions of pregnancy; women purposely 
avoid fetal antidepressant exposure; and antenatal screening is not routinely performed 
(Stowe et al. 2005).   
Thus the articles convey an urgent need to begin screening for depression during 
pregnancy.  They assert that early diagnosis and treatment produce the best obstetrical 
outcome and prevent negative consequences for the infant, the family, or the woman.  
Recommended treatment most often includes medication, with its risk of harm to the 
fetus or breastfed infant weighed against its benefit (Jermaine 1995; Rubin 2000).  Rubin 
(2000) asserts that studies that emphasize harm to the fetus when women take drugs in 
pregnancy fail to note the implications when they do not take the medicine.  Social  
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support and counseling are recommended less frequently than medication.  “The impact 
of depression during pregnancy may still be controversial but the impact of stress/anxiety 
is quite well-accepted” (Halbreich 2005: 1313).   
A theme repeated throughout the articles is that depression consists of recurring 
episodes.  A prior episode of depression is the most often cited cause for developing 
PPD, and 31 percent of the articles in the sample implicate prior depression as a major 
cause of PPD.  Medical professionals advise that early diagnosis and treatment are 
necessary to prevent depression from becoming a chronic illness and to lessen the chance 
of recurrence (Trad 1995).  The finding that 53 percent of the women with PPD in one 
study were depressed five years after delivery suggests that women with PPD may be 
vulnerable to recurring episodes within four years, without undergoing another pregnancy 
(Pop et al. 1995).  This finding conveys the need to continue surveillance beyond even 
the extended postpartum period, as exposure to subsequent relapse of maternal depression 
beyond the first year increases the risk of diminished cognitive development and future 
adversities for children when their mothers have PPD (Halbreich 2005; Logsdon et al. 
2005; Gentile 2005).  The risk of recurrence calls for a broad, comprehensive approach to 
address the “multidimensional interactive processes” involved in the disease of PPD 
(Halbreich 2005: 1319).  With such dire consequences, doctors recommend the continued 
use of medication for 9 to12 months after the depression remits in order to prevent 
relapse (Stowe 1995; Horowitz and Goodman 2005).     
The postpartum period is considered a developmental period in the life course 
(Gruen 1990), temporal and transitional in nature, and some of the articles suggest that  
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PPD is also transitional and remits on its own.  Goodnick et al. (2000) assert that most 
cases of PPD resolve naturally within three to six months; Blenning and Paladine (2005) 
find that if left untreated, PPD lasts generally about seven months; and Beck (1995) 
suggests that it remits within one year.  However, these authors also suggest that better 
screening increases diagnosis rates and facilitates identification and treatment of high-risk 
women (Blenning and Paladine 2005); that medical professionals add to women’s shame, 
embarrassment and guilt by suggesting that what they are feeling is normal (Beck 1995); 
and that symptoms go beyond the patient, from the mother/infant duo to the entire family 
(Goodnick et al. 2000).  Thus, even though postpartum depression is considered a 
temporary condition, medical intervention is encouraged.   
Some of the articles indicate a reluctance to medicate pregnant or breastfeeding 
mothers even while encouraging awareness and prevention of the disease.  Corral, Kuan, 
and Kostaras (2000) suggest the use of bright light therapy in lieu of medicating 
breastfeeding mothers.  Stowe (1995) finds that physicians are under consumer pressure 
to diagnose and treat such conditions as PMS and PPD, even though the effects on the 
infant’s nervous system are unknown and the side effects of antidepressants are similar to 
PPD symptoms: anxiety, headache, and insomnia.  Horowitz and Goodman (2005) find 
that although the use of antidepressants improved the symptoms of depression for the 
women in one study, other factors (such as the passage of time) may have contributed to 
their recovery.  Thus while PPD is a temporally-situated condition that apparently 
resolves without treatment, and alternatives to medication exist, medical professionals 
focus on improving diagnosis and treatment that most often includes medication.   
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Tired, sleepless, happy…and other symptoms of PPD 
 The early articles tend to examine single biological, emotional, or social aspects 
as possible causes of PPD, while some of the later articles move toward a multifactorial 
focus on its causes.  The most common causes of PPD (see Table 4) according to  
the sample articles are prior depression or lack of family support; 32 percent of all the 
articles in the sample suggest that a mother who suffered a previous episode of  
 
 
 
Table 4: Causes of postpartum depression: percentages by year and by database  
 
  1950 1980 1985 1990 1995 2000 2005 
 
Hormones Medline 100 50 50 43 29 33 28 
 LexisNexis 0 0 0 0 63 13 24 
         
Prior Depression Medline 0 50 0 43 50 39 50 
 LexisNexis 0 0 0 0 13 13 10 
         
Stress Medline 0 50 0 50 43 23 44 
 LexisNexis 0 0 0 0 25 13 15 
         
Family Support  Medline 0 50 50 65 50 28 50 
 LexisNexis 0 0 0 0 63 0 10 
         
Marital Relationship Medline 0 50 0 57 36 22 45 
 LexisNexis 0 0 0 0 50 0 5 
         
Note: Percentages in Table 4 do not add up to 100 percent because some articles 
mention multiple causes of PPD.   
 
depression is at greater risk for PPD, and 36 percent suggest that lack of family support is 
the main cause of PPD.  Pop et al (1995) maintain that the most important predictors of  
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PPD are prior depression and a family history of depression.  Marital status and age of 
the mother also make some women more vulnerable to PPD; 17 percent of all the articles 
indicate that unmarried mothers are at greater risk for developing PPD, and 16 percent 
suggest that young mothers have increased vulnerability, with the prevalence for 
adolescent mothers as high as 47 percent (Logsdon et al. 2005).    Only four of the 
articles (six percent) suggest that fathers can have PPD, and three (four percent) suggest 
that other family members can have PPD.   
The most cited biological symptoms include appetite changes, fatigue, and 
insomnia.  Emotional symptoms most often include anxiety, as well as sadness and/or 
thoughts of suicide; behavioral symptoms include crying and irritability.  Stover and 
Marnejon (1995) suggest that symptoms of PPD are pleas for help by women to cope 
with the emotional distress of motherhood.  Horowitz et al. (1995) find that a “cluster of 
symptoms” is more common in PPD than other depressive disorders: feeling worse in 
evening, difficulty falling asleep; irritability; phobias; anxiety; OCD; sometimes suicidal 
thoughts and anxiety disorders (see Table 5). 
Saks et al. (1985) suggest that the relative well-being, joy and euphoria that 
women feel immediately after giving birth may mask symptoms of depression and 
therefore clinicians may miss symptoms of depression when the patient is discharged 
from the hospital.  “The relatively good mood shown by women at time of delivery is 
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Table 5:  Symptoms of postpartum depression: percentages by year and by 
database. 
 
  1950 1980 1985 1990 1995 2000 2005 
 
Anxiety Medline 0 100 100 43 50 34 28 
 LexisNexis 0 0 0 0 50 13 5 
         
Appetite Changes Medline 0 50 100 22 36 28 34 
 LexisNexis 0 0 0 0 13 0 5 
         
No Energy/Fatigue Medline 0 100 100 65 50 17 39 
 LexisNexis 0 0 0 0 50 13 10 
         
Insomnia Medline 0 100 100 50 57 39 50 
 LexisNexis 0 0 0 0 50 13 15 
         
Sadness Medline 0 100 100 43 29 17 28 
 LexisNexis 0 0 0 0 38 0 5 
         
Thoughts of Suicide Medline 0 100 50 36 29 23 23 
 LexisNexis 0 0 0 0 25 25 19 
 
Note: Percentages in Table 5 do not add up to 100 percent because some articles mention 
multiple symptoms of PPD.   
 
worth stressing,” and may be labeled “postpartum pinks” in order to distinguish such 
elation from the “normal” postpartum blues (Saks et al. 1985: 730). The positive 
emotions exhibited following delivery are also implicated as signs of bipolar disorder, as 
depression sets in after the initial highs of childbirth (Stowe 1995; Grof et al. 2000).  
Thus medical professionals assert that mothers may be depressed even when they are 
happy.  
Several of the articles indicate that the symptoms of general depression are very 
similar to the “normal” postpartum period – fatigue, weight loss, disturbances in eating 
and sleeping patterns, mood disturbances, psychomotor retardation, change in body 
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image, and loss of libido (Stowe 1995; Horowitz et al.1995; Johnson 2000; Ugarriza 
2000; Maes et al. 2000; Stowe et al. 2005; Leung et al. 2005; Garg et al. 2005).  The 
overlap in symptoms associated with general depression and symptoms of the normal 
postpartum period may lead to a failure to diagnose PPD (Horowitz et al.1995).  Further, 
women and their clinicians may mistake the symptoms of antenatal depression for those 
of pregnancy (Stowe et al. 2005).  Some authors suggest that women with PPD exhibit 
more severe anxiety, panic attacks, crying spells, irritability, and hostility (Maes et al. 
2000; Gentile 2005).  For example, Boyer (1990) suggests that a new mother suffers 
depression if she has 15 or more episodes of crying in any 60 days before or after 
delivery.   And Saks et al. (1985) find that depressed women self-rated themselves as 
more lonely, angry at themselves, distressed, lacking feeling of well-being, angry at 
others, shy, and defeated than non-depressed women.  Thus medical researchers seek to 
identify unique symptoms that suggest depression in postpartum women.  To distinguish 
between normal postpartum and antepartum conditions and PPD, Unterman et al. (1990) 
assert that the DSM revision should have a separate diagnostic category that considers the 
special problems that postnatal women have.     
The distinguishing feature of PPD as proposed in the articles is mercurial mood 
lability and an inability to adjust to the new responsibilities of motherhood (Stowe 1995; 
Vandenbergh 1980; Saks et al. 1985; Gruen 1990; Unterman et al. 1990; Casiano 1990; 
Trad 1995).  The authors indicate that PPD is a form of “psychological morbidity” 
(Forman et al. 2000: 1215; Gamble et al. 2005), one of several disorders occurring in the 
antenatal and postnatal periods (Garg et al. 2005).  Such disorders include bipolar 
disorder (Stowe 1995; Grof et al. 2000; Heron, Craddock and Jones 2005), eating 
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disorders (Franko and Spurrell 2000), post-traumatic stress disorder (Gentile 2005; 
Gamble et al. 2005), postpartum obsessive-compulsive disorder (Horowitz and Goodman 
2005), and a wide spectrum of anxiety disorders (Gentile 2005).  It appears that PPD is 
but one ailment that can negatively impact a woman’s life.  Thus, the postpartum period 
is “one of the most critical phases of a woman’s life” in which she is most likely to 
develop PPD or severe psychiatric disorders, “especially the affective type” (Gentile 
2005: 945).     
Verkerk et al. (2005) suggest that personality plays an emerging role as a risk 
factor for depression, asserting that neuroticism (characterized by tension, emotional 
lability and insecurity) and introversion (inhibition and shyness in social situations) 
predispose individuals to depression.  Further, some women with depression are believed 
to have “avoidant personality disorder” (Pearlstein et al. 1990: 132), which consists of 
social inhibition, feelings of inadequacy, and sensitivity to negative evaluations; or they 
may have a personality disorder such as alcoholism or drug abuse (Casiano 1990).   
 
Call the Doctor 
 Some authors suggest that every postpartum woman needs a mental health 
assessment just as she needs a physical assessment, and health care professionals have 
unique opportunities to assess the functioning and adjustment of postpartum women 
(Horowitz et al. 1995).  However, health care professionals are just now becoming aware 
of PPD (Feingold 1995).  As a result, health care providers rarely see signs of PPD or 
adjustment difficulties (Gruen 1990), possibly due to a lack of awareness or knowledge 
of the disease or for a lack of time spent with each patient (Glasser et al. 2000).  Thus, 
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postpartum depression is rarely diagnosed even though up to 20 percent of families with 
new babies are affected (Gruen 1990).  However, the role of medical professionals 
increasingly is to screen for depression (see Table 6).   
Table 6: Recommended Course of Action for Medical Professionals to Mothers 
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 The primary source for medical care of the pregnant woman is the obstetrician, 
who follows the progress of the pregnancy and the birth.  The role of the obstetrician 
generally ends with the postpartum checkup six weeks after delivery; therefore, other 
health care professionals are being trained to recognize symptoms of PPD and identify 
and treat women who may be depressed.  PPD education for all “points of service” – 
health care professionals in the obstetrical, primary care, and pediatric fields – provides 
opportunities for early intervention to prevent harmful consequences to the entire family 
(Garg et al. 2005: 592).  The primary care physician, hospital support staff, nurses, and 
social workers are alerted to look for signs of depression that include the patient’s words, 
facial expressions, grooming, body language, and interaction with the infant (Auerbach 
and Jacobi 1990; Berchtold and Burrough 1990).  Midwives and childbirth educators play 
an expanding role in the postpartum period by mentoring new mothers, educating them 
about postpartum symptoms that are beyond the “normal” adjustment to parenthood for 
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the sake of early detection and treatment (Feingold 1995).  Clinicians are encouraged to 
ask specific questions regarding the transition to motherhood in conversational style that 
allows potentially depressed women to reveal stresses of their new parental roles (Beck 
1995).   
Casiano (1990) suggests that the goal of health care providers is to summarize 
symptoms and label the disorder as maternity blues, mild to severe postpartum 
depression, or postpartum psychosis, and to help the mother raise her children in a 
healthier environment.  Stover and Marnejon (1995: 1471) assert that physicians should 
provide a comprehensive approach with “anticipatory guidance” for new mothers and 
their families which gives them a more realistic view of pregnancy, childbirth, and 
parenthood.  Physicians are encouraged to focus on prevention through early 
identification and treatment (Feingold 1995).   
The nurses’ role expands to include assessing the emotional adaptation of women 
to pregnancy and motherhood, and this assessment continues throughout the entire 
childbearing cycle as well as through subsequent pregnancies (Auerbach and Jacobi 
1990).  Their knowledge of PPD is an essential aspect of caring; through intuition and 
knowledge of PPD they can “make astute observations that something might be wrong 
with the mother” and refer her to the appropriate source, guiding her to the path of 
recovery (Beck 1995: 822).  Nurses in the maternity hospital setting as well as those who 
have outpatient contact with mothers, such as pediatric, obstetrical, and primary care 
nurses, are asked to observe signs of maladaptation and to make appropriate referrals to 
medical professionals for treatment (Auerbach and Jacobi 1990).  In conversational style, 
they convey empathy and assist the mother in obtaining support from family, neighbors 
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or friends who can “mother the mother,” giving her food and rest from the demands of 
motherhood (Auerbach and Jacobi 1990: 380; Kirkey 1995).  They are encouraged to 
observe tone and body language of mothers to detect signs of depression in “women in 
the throes of illness,” to become educated about PPD by reading available literature and 
attending lectures or conferences, and to implement postpartum support groups in the 
hospital or community (Berchtold and Burrough 1990: 387).  A further suggested role for 
nurses includes to police compliance with recommended therapies to ensure that 
depressed women follow through with the appropriate treatment (Horowitz and Goodman 
2005).  “Often the primary nurse must serve as the conduit through which the entire 
health care team considers all family members’ needs” (Auerbach and Jacobi 1990: 383).  
 Health care providers often consider their work done when the physical health of 
the mother and baby are attained after labor and delivery; however, their responsibility 
continues into the postpartum period to ensure their psychological and emotional health 
as well (Boyer 1990).  A primary role for obstetricians and nurses whose patients are 
pregnant women is preventing PPD by dispelling myths of pregnancy which first-time 
mothers learn from experienced mothers (Tentoni and High1980).  Maternity or 
childbirth classes aim to replace lay knowledge with scientific, factual knowledge and 
thereby counteract negative views of pregnancy and motherhood.   Women’s experiential 
knowledge is considered not only erroneous but harmful.  
 
What’s your score? 
 
 Screening is a major component for diagnosing PPD, permitting intervention 
before symptoms become disabling to the mother and harmful to the child.  Some authors 
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suggest the need for standardized screening instruments for optimal diagnosis, as well as 
a broader set of risk factors that are more sensitive to PPD (Horowitz and Goodman 
2005; Halbreich 2005).   A popular depression screening tool, the Beck Depression 
Inventory (BDI), is a 21-item questionnaire in which individuals self-rate their mood, 
conscious thought, and symptoms of depression (Saks et al. 1985).  However, the BDI 
has been criticized because its questions are not specific to the childbearing experience, it 
may miss some cases of subclinical depression, and the symptoms of postpartum 
adjustment disorders are not differentiated from general depression (Horowitz et al. 
1995).  In addition, it may give false positives because it is sensitive to symptoms that are 
“normal” changes after childbirth, such as sleep disturbances, weight loss, fatigue, and 
loss of libido (Ugarriza 2000; Leung et al. 2005).   
 The Edinburgh Postnatal Depression Scale (EPDS) was designed specifically to 
screen for PPD; it improves identification of high-risk women and diagnosis rates, and it 
facilitates treatment (Ugarriza 2000; Blenning and Paladine 2005; Cox 2005).  Its 
limitations include that it does not provide mothers with an opportunity to describe their 
symptoms fully (Beck 1995), that it only tests postpartum, not in pregnancy (Agoub et al. 
2005), and that it lacks cultural relevance outside of western society (Banerjee et al. 
2000).   
Other screening tools include the Postpartum Depression Checklist (PDC), a 
“simple practical device” designed to engage a woman in conversation about her 
experiences with the 11 symptoms on the checklist (Beck 1995: 310), and the Antenatal 
Psychosocial Health Assessment (ALPHA).  ALPHA was designed to systematically 
identify areas of psychosocial concern, listing 15 risk factors associated with woman 
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abuse, child abuse, PPD, and couple dysfunction; it doubles the detection of psychosocial 
concerns among pregnant women (Carroll et al. 2005).  
Unterman et al. (1990) assert that women tend to underreport their symptoms 
because of shame, guilt, or embarrassment, and that because of limited direct observation 
by medical professionals, family members are responsible for recognizing symptoms of 
depression in the mother and seeking medical help when necessary.  Women may be 
depressed at the postpartum checkup but unaware of diagnosis as they mistake distress as 
the blues or fatigue; symptoms then evolve into a major depressive episode with impaired 
functioning (Beck 1995).  Psychosocial experiences interfere with a woman’s ability to 
adjust to motherhood; therefore screening instruments with psychosocial values may 
identify women at risk (Unterman et al. 1990).  Horowitz and Goodman (2005) suggest 
that the high prevalence and negative consequences of PPD require a change in 
healthcare policy to mandate universal postpartum screening as standard care in the U.S.   
Poor detection needs to be improved through tailored screening tools (Beck 1995) and 
universal screening programs.   
 
 
CHAPTER 4 
DISCUSSION 
Although PPD was recognized centuries ago during the time of Hippocrates, it 
has only recently received much attention.  The current sample of articles reflects a 
trajectory of increasing volume since 1990 that illustrates the social narrative occurring 
around the issue.  That narrative changes over time, from examining the significance of 
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single etiological elements, such as hormones or lack of family support, to a combination 
of multiple factors that purportedly make women vulnerable to PPD.  And although a 
definitive etiology remains elusive, treatment options change from social support for 
mothers in their childrearing responsibilities to medication as the current preferred 
treatment recommended by medical professionals.   
The articles illustrate, map, and justify an expansion of medical control over 
women’s bodies to include not only physical aspects of childbirth but psychological and 
emotional aspects of pregnancy and the postpartum period as well.  The PPD issue 
parallels the movement of childbirth into the medical model as women’s emotions are 
pathologized, and as medical experts promote their knowledge to allegedly lower the risk 
of harm to the baby, giving greater control to medical professionals while further eroding 
women’s voice and agency.  Just as Rothman (1982) finds it more difficult to have an 
uncomplicated pregnancy – not because of complications but because of medical 
intervention and innovative technology – it is becoming more difficult to be “normal” or 
symptom-free in the postpartum.  The extended timeline for vulnerability to onset, the 
expanded list of symptoms specific to the postpartum, and the increased surveillance by 
multiple medical practitioners and vague screening instruments push more women into 
the complicated pregnancy category that includes clinical depression.  And just as 
obstetrical practices carve procreative time into specific categories that delineate 
progression of the pregnancy, of the developing fetus, and of labor that disempower 
women in the process of childbirth (Simonds 2002), medical professionals establish time-
defined periods of postpartum, of vulnerability to onset of depression, and of duration of 
the illness that affect women’s diagnoses. 
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“Temporal differentiation” affects the way we classify the world, imbuing 
meaning that becomes reified in everyday social life (Zerubavel 1991: 10).  The articles 
show an expansion in the timeline of surveillance of women’s moods, beginning in 
pregnancy and continuing through an extended postpartum period that remains open-
ended.  Temporality is evident in the portrayal of the childbearing years as a 
developmental period rife with vulnerability to psychiatric disorders, of which PPD is 
only one.  Women are said to be vulnerable to depression anywhere from 10-14 days 
postpartum to three months, six months, one year, or five years and beyond, even into 
grandmotherhood.   
Temporality is also evident in the definition of PPD, as the time of onset of 
symptoms lasting more than two weeks determines whether the woman is diagnosed with 
the “normal” condition of “baby blues” or postpartum depression.  The difference 
appears to be not in the severity of symptoms but in the timing of onset and duration of 
symptoms.  And although some articles refer to PPD as a time-limited experience and 
suggest that it readily remits without treatment within a few months to one year, the 
articles convey a sense of urgency and crisis that requires immediate medical 
intervention.   
Intervention of medical professionals is encouraged through an education 
campaign that informs obstetricians, pediatricians, primary care physicians, nurses, social 
workers, hospital staff – and women – of the signs and symptoms of the disorder as well 
as the dire consequences that occur when the malady is left untreated.  When the mother 
is fully functioning in her role, the infant supposedly attains optimal physical, emotional, 
and cognitive development; the spousal relationship thrives; and the whole family is 
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healthy, each member nurtured and loved by the mother.  When the mother is not fully 
functioning, the infant is dependent, fussy, neglected or abused, with physical, emotional 
and cognitive impairment that affects future potential.  The couple’s relationship is 
threatened, filled with tension due to lack of communication, lack of sexual expression, 
and the mother’s unattractive appearance.  The family is disorganized, chaotic, stressed, 
and in crisis.  The education campaign promotes the intergenerational transfer of 
depression with the assertion that the child’s future potential is stunted by the mother’s 
depression, that children of depressed mothers are socialized to react to mild stress with 
anxiety, and that a woman’s own experience of being mothered shapes her ability to 
mother.  Further, it conveys the urgency of curing depression for the sake of preventing 
future episodes of depression, as a family history of depression or a prior episode of 
depression is said to predispose women to PPD.     
Medical professionals determine what is “normal” behavior for mothers, monitor 
their conformity to these behavioral norms by observing and conversing with them, and 
diagnose and treat those who are unable to fulfill such expectations.  Personality, biology, 
biography, and other individual traits are said to make some more vulnerable to failure to 
develop an adequate maternal identity, thus causing PPD.  The increased risk to certain 
groups – young, unmarried, previously depressed women, women who faced childhood 
adversities – is magnified in light of the ideology of the perfect mother, their 
vulnerability to depression heightened because they are further from the ideal to start 
with.  The medical profession becomes a redeemer of sorts, the hero who removes the 
blame from the miserable woman who struggles with ineptitude at motherhood.   
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The influence of ideology on motherhood is ubiquitous.  It causes mothers to feel 
incompetent, overwhelmed, isolated and afraid to express negative emotions about the 
mothering experience.  The articles imply that the result of depression in mothers is harm 
to the child (developmentally, emotionally, physically, cognitively), harm to herself (in 
her maternal identity), and harm to the family (through stress, crisis, disorganization).  
With such dire consequences, mothers who lack confidence to adequately care for and 
love their infant succumb to medical control, possibly with relief through medication 
such as Shields indicated.  Blame and stigma are lessened as the difficulties in the 
postpartum period are made real rather than imagined, given a name, common symptoms, 
and treatment options that offer the hope of recovery.  Few of the articles in the total 
sample (six percent) indicate that fathers or other family members experience PPD, 
although they are adversely affected by the woman’s depression.   
It is important to note that the increase in frequency of articles coincides with the 
1987 introduction of the first SSRI antidepressant, Prozac, to the U.S. market (Healy 
2004; www.mayoclinic.com).  The rate of depression in the general population since then 
has increased 1000-fold (Healy 2004).  Similarly, Bouchez (1995) asserts that there has 
been either a true rise in incidence of PPD or an increase in those reporting its symptoms, 
as the prevalence rate is closer to 30 percent than the 10-15 percent normally reported.  In 
addition, Hendrick (2000: 70) finds that the women with PPD in his/her study were 14 
times more likely to be on two antidepressants than the non-postpartum depressed group, 
and suggests that “polypharmacy” shows greater physician concern for postpartum 
women that includes earlier use of additional psychotropic intervention.  This finding 
contradicts past medical practices that carefully spell out what should and should not be 
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ingested during pregnancy and while breastfeeding.  The suggestion that the risk of 
medication to the developing fetus is less harmful than the effects of a mother’s 
depression is a complete reversal from the pharmacologic abstinence usually practiced 
during pregnancy.   
While discourse surrounding postpartum depression opens the door for women to 
express negative aspects of mothering without the risk of social condemnation, the 
movement toward the medical model defuses pressure to remediate the tremendous and 
disproportionate responsibility that mothers bear for the physical, emotional, and 
cognitive development of their children.  It leads to the diagnosis and treatment of 
individual women rather than a change in the societal expectation that women be perfect 
mothers.  The focus is no longer on the difficulties of mothering and the dissonance 
between ideological representations of motherhood and reality but on the scientific 
representation of PPD as a disease.  Women who fail to meet the standards of mothering 
simply become patients, and medical professionals offer the hope of recovery.   
 
Applied Implications 
 The emerging constructions of PPD represent the expansion of social control over 
women’s bodies, not through overt oppression but through the medical diagnoses of 
psychological and emotional disorders.  In the spirit of inquiry about postpartum 
depression’s effect on women’s lives, I question whether defining PPD as an illness, and 
particularly prescribing medication as treatment, improves women’s lives.  Although 
medication may provide a “quick fix” for women suffering from depression in the 
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postpartum, the practice of medicating social problems removes the potential for social 
change as it locates the problem within the individual.     
 According to Taylor’s (1996) model of PPD, women’s self-help movements 
redefine gender relations and renegotiate motherhood through the discussion of 
postpartum illness in the popular advice literature.  In support groups, women build 
solidarity with others with shared experiences, enhance their feelings and perceptions 
about themselves as well as their confidence when dealing with medical, legal, and other 
professionals, and promote social and personal change.  While I agree with Taylor that 
support groups offer women a platform to convey their personal realities of motherhood 
and that competing discourses arising from their shared experiences challenge traditional 
notions of motherhood, I question whether social change would occur as a result.  My 
analysis shows that the medical profession increasingly recommends medication over 
social support or counseling as the preferred treatment, which removes the impetus for 
social change and instead finds its remedy in treating the individual mother.  The 
increased use of medication represents a change in direction of treatment since Taylor’s 
book was published in 1996.   
 Ironically, Taylor finds that women are at the forefront of the push to have PPD 
recognized as a distinct illness with its own categorization in the DSM.  My study also 
finds that more authors in my sample are women than men, and more medical doctors 
than any other credential, which seems an anomaly.  After all, how can one say that the 
medicalization of PPD disempowers women and reflects the patriarchal nature of the 
medical profession when it is women who are writing the articles?  Perhaps an answer 
may be found in Berger and Luckmann (1967: 85) who find that “subuniverses” of social 
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meaning result from melding institutional knowledge with biography, illustrating “a 
dialectic between social production and the objectivated world that is its product”: 
 A body of knowledge, once it is raised to the level of a relatively autonomous  
 subuniverse of meaning, has the capacity to act back upon the collectivity that  
 has produced it. For instance, Jews may become social scientists because they  
 have special problems in society as Jews. But once they have been initiated into  
 the social-scientific universe of discourse, they may not only look upon society 
 from an angle that is no longer distinctively Jewish, but even their social activities 
 as Jews may change as a result of their newly acquired social-scientific  
 perspectives. (Berger and Luckman 1967: 86-87, emphasis in original)   
 
Established disciplines such as medicine train candidates in their traditions, and 
regulatory practices such as review boards and certification requirements uphold the 
practice of those disciplines.  Women who enter the medical profession acquire medical 
knowledge that is imbued with patriarchal values which influence their medical practice 
and their perceptions of illness and disease.   
 The diagnosis of PPD infers disease from behavior, specifically failure to conform 
to gender roles.  When PPD is defined as an illness, women who receive a diagnosis 
escape condemnation for failing at motherhood, after all, medicine is there to help the 
mother, not to condemn.  And a diagnosis has real advantages – in court, in building 
solidarity among women, and in furthering discourse surrounding motherhood.  But 
locating women in the patient frame is helpful only up to a point; centering them in the 
medical model pathologizes their experiences and removes agency.  Mothers with PPD 
are viewed as abnormal, deviating from the standards of maternal behavior.  Women 
diagnosed with PPD may be viewed as “patients” first and political actors second, 
illustrating the potential for disempowerment because of the patient label.  Having failed 
at mothering, even if through no fault of their own, the label can be stigmatizing, can 
limit their degrees of freedom and keep their primary status as “patient” rather than 
  61 
 
“woman.”  And as patients, their demands for social reform become less imperative as 
medicine is readily available to bring the struggling mother up to par.  Medication pulls 
mothers “back from the brink” and restores their ability to function as mothers.  If the 
behavior of women with PPD is viewed as irrational, it may lead others to view women 
in general as irrational much as the focus on moods during the menstrual cycle and 
menopause has negatively affected the perception of women’s emotional stability.   
 For an illness category so poorly defined and still debated, it is alarming and 
perhaps premature that such practices as mandatory depression screening for all postnatal 
women – legislated in New Jersey in 2006 and proposed in Illinois – are coming into 
play, especially in light of screening instruments that are vague and difficult to interpret.  
For instance, one of the 10 items on the Edinburgh Postnatal Depression Scale (EPDS) 
states, “Things have been getting on top of me,” to which mothers are asked to underline 
the response which comes closest to how they have felt in the past week:    
 Yes, most of the time I haven’t been able to cope at all   
 Yes, sometimes I haven’t been coping as well as usual   
 No, most of the time I have coped quite well    
 No, I have been coping as well as ever   (see Appendix B). 
 
Responses are scaled, and the total score determines the presence and severity of 
depression, which then requires further clinical assessment.   
 The increasing rates of depression in pregnancy and the postpartum reflect 
problems in living rather than a disease, and the medical model individualizes what might 
be social issues of gender inequality.  Clinicians should be aware that the diagnostic 
category of PPD has a short social history with its recent constructions, and the potential 
for over-prescribing medication exists, which can have detrimental effects on infant and 
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mother.  Physicians rely on information supplied by pharmaceutical companies for new 
products and approaches to treating illnesses, yet the long-term effects of antidepressants 
on the fetus, on the breastfed infant, or on the mother have yet to be determined.  The 
question remains as to who benefits from diagnoses of depression – the mother, the 
infant, medical professionals, or outside interests such as drug companies.   
  
Theoretical Implications 
Critical constructionists and postmodern feminists would recognize the imbalance 
between the authoritative medical professional and the vulnerable woman.  For instance, 
women’s emotionality is often referred to as the “affective type” throughout the articles, 
“aberrant emotions” associated with behaviors such as crying more than 15 times in any 
60-day period.  The gendered aspect of depression diagnoses is evident in the reference to 
“postpartum pinks,” a state of elation immediately following childbirth that is said to 
mask depression and possibly be a sign of bipolar disorder.  Ironically, women are said to 
be depressed even when they experience joy at childbirth.  A comparable condition might 
be a “runner’s high” which occurs following strenuous exercise or physical exertion; 
would the same implication of bipolarity or masked depression apply to athletes, whose 
composition includes both genders?   
Medical professionals promote ideological representations of motherhood, 
bolstered by such scientific concepts as “intuitive” mothering behaviors, which shape 
maternal identities.  Laden with ideology of the good mother, the articles romanticize 
motherhood and support an unreachable standard by which all mothers are judged.  The 
focus is on the mother-infant dyad and intuitive mothering behaviors such as 
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instantaneous mother/infant bonding, vocal and visual cuing, and maternal patterns of 
empathic interaction with the infant.  Idealized versions of motherhood and the perfect 
transition from couple to family are portrayed as the “normal” state of motherhood.  
Guilt, shame, depression, and sense of failure are the consequences of one’s failure to 
attain.  The cultural expectation that women will become mothers despite societal 
attitudes that devalue motherhood creates a sense of disillusionment which new mothers 
often describe as feeling angry, entrapped, isolated, and hostile.  The articles implicate 
the dissonance between such high expectations and reality, which creates a sense of 
failure for mothers.  The influence of the medical profession on women’s maternal 
identities supports feminist and constructionist recognition of imbalances of power. 
The assertion that mothers are unaware that they are depressed, that they mistake 
their symptoms for those of fatigue and lack of sleep supports Foucault’s theoretical 
assertion that individuals undergo a process of self-understanding mediated through an 
external authority figure, in this case the medical professional.  Screening instruments 
assume knowledge of all women’s experiences in the motherhood role and assess their 
ability to adapt based on those assumptions.  Foucault asserts that the individual is the 
ideological representation of society, but power (specifically biopower) produces reality, 
domains of objects and rituals of truth anchored in consensual relationships.  Power, then, 
is not a pure and simple projection upon individuals but is enforced through a multitude 
of institutions – medicine, the family, religion, the state.  Through scientific 
classification, the individual defines who they are; normative expectations tell us how to 
behave and what actions to take.  The ideology of the “good mother” supported in the 
articles tells us what motherhood should be and what mothers should experience.  
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Presented as truth, experts present a normative ideal of motherhood that constructs the 
standards of motherhood.  Thus, the power of medical experts’ knowledge normalizes the 
expectations of motherhood by which all women are judged.   
Women who undergo screening evaluate their own experiences through the 
preconceived representations on the screening instrument.  Their mothering experiences 
are framed through the eyes of the medical profession and upheld through the influence 
of family, religion, and state policies, setting standards for mothering that shape maternal 
identities.  Disciplinary power through surveillance – by medical authorities, family, and 
state policies – results in the objectification of women who self-diagnose according to the 
checklists of symptoms, and the individual woman regulates and achieves conformity to 
the normative expectations of motherhood by seeking medical intervention when 
necessary.  As Foucault asserts, normalizing individuals occurs within the body of people 
and optimizes the well-being of each individual; it is used for the good of the state and to 
protect the lives of its people.  This is visible in the issue of PPD, as the medical 
profession creates an image of motherhood which society accepts and allows it to shape 
its attitudes and actions toward motherhood.  Medicalization operates as social control at 
the “capillary level” (Foucault 1980: 39), not from above or below but from all social 
relationships, constraining individual bodies and governing individual actions and 
attitudes through the discourse of PPD.  Through ideological representations and medical 
categorization, women conform to societal expectations of motherhood; through 
medication, the depressed woman becomes a good mother for the protection and 
nurturing of the infant and the family.  Thus the medical model and the current 
constructions of PPD produce Foucault’s concept of docile bodies.   
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Conformity to the standards of motherhood occurs as discourse strengthens the 
ideal as the norm, as in Gramsci’s concept of hegemony.  Mothers willingly conform to 
treatment protocols because “experts” deem that treatment to be in their best interest for 
the health and protection of the infant and family.  The authority which the medical 
profession exerts in the discursive formation of PPD can be seen in the Tom 
Cruise/Brooke Shields debate.  Authors of the LexisNexis articles in the sample quickly 
renounced Cruise’s statements as a rant and an irresponsible disservice to women.  They 
pointed out his lack of a medical degree as evidence that he is unqualified to speak about 
the issue.  Although his message may have been valid, the focus became his irrational 
behavior, awarding a point to the medical side and a penalty to those who would question 
medical intervention for PPD, furthering medical dominance and control in the 
postpartum debate.   
 
  
CONCLUSION 
Analysis of a sample of medical and popular literature on postpartum depression 
shows that the process of medicalization extends medical control over women’s lives 
during the childbearing years beyond the physical to include emotional and psychological 
aspects as well.  The articles in both the Medline and LexisNexis databases are similar in 
their medical representations of PPD; some of the articles in the LexisNexis database also 
present PPD in non-medical context.  The common use of the term in non-medical 
sources indicates a general acceptance and understanding of the conditions inherent to 
PPD among non-medical populations.   
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The expansion of the medical domain is evident in the timing of onset – which 
now extends well beyond the traditional four- to six-weeks postpartum as well as back 
into pregnancy – and the evolving list of depressive symptoms unique to pregnant and 
postpartum women.  The expansion is also evident in the number of professionals in 
various medical fields – obstetrics, pediatrics, family practice, nursing, psychiatry, social 
work – trained to diagnose and treat PPD, as well as in the development of new screening 
instruments and programs designed specifically to identify women at risk.      
The emphasis on monitoring women’s moods and treating women in order to 
support the family tightens the boundaries of motherhood, enforcing cultural ideologies 
of the good mother.  The expectations of motherhood are more firmly set as the medical 
profession defines what emotions are normal in the transition to motherhood.  The 
medicalization of PPD results in the treatment of individual women, most often with 
medication, with negative implications for women that include the label of “patient” that 
sticks and results in a lifetime of surveillance, the pathology of normal emotions as 
“aberrant” rather than human, and with such practical concerns as hindering the ability to 
obtain life insurance once diagnosed with PPD (Lieber 2007).  The mother alone 
experiences PPD in the transition to parenthood; fathers and other family members are 
rarely diagnosed with PPD but are said to suffer the effects of the mother’s depression.   
Ideological representations of motherhood – such as intuitive mothering behaviors and 
expectations of joyful mothering experiences – coupled with adverse, long-term 
consequences to the child and the family when such ideals are not attained compel 
women to seek treatment.  Rather than ameliorating the effects of a difficult transition 
through social support, medication is the preferred remedy for the individual mother who 
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struggles in her motherhood role.  Thus, medicalization standardizes emotions and 
behaviors that support idealized versions of motherhood and upholds gender inequality 
inherent in traditional parenting roles. 
 The increase in the frequency of articles and the education campaign to raise 
awareness about PPD coincide with the 1987 introduction of the SSRI antidepressant 
Prozac to the U.S. market.  The shift away from social support to medication as the 
preferred treatment implicates the marketing of pharmacology in the push to establish 
PPD as a treatable disease.  The education campaign to inform medical professionals and 
mothers about the signs and symptoms of PPD produces more “awareness” about the 
disease, and treatments are designed to prevent harm to the child and to lessen the risk of 
recurring episodes of depression.  Women who experience an episode of depression will 
be under increased scrutiny during each subsequent pregnancy, postpartum period, and 
any future stressful life event, expanding medicine’s gaze into women’s lives.   With this 
marketing strategy, the prevalence rates of mothers who are depressed increase…as do 
profits for the drug companies.  Yet the fate of not only the present but the future remains 
heavily on the woman’s shoulders.  The hierarchy of medical authority reinforces gender 
inequality as it more firmly establishes women’s role as the primary caregiver for 
children.   
 The push to screening for depression in the pre-partum and in longer periods 
postpartum and to medicating women who are diagnosed raises the alarm to unravel the 
process of medicalization rather than accept it.  A close reading of a careful sample of 
both medical and popular sources reveals nuances in the ways that medicine and 
medicalization play out, not only furthering the scientific rationale for expanded controls 
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over women’s lives, but also justifying pharmaceutical involvement.  As a result, I come 
away with a picture of the process as entrenching the hierarchy of medicine and 
tightening the boundaries of motherhood.    
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Appendix A:  Code Sheet 
Section 1 
1.  Article # __________ 
2.  Location 
1 Medline 
2 LexisNexis 
3.  Year published (4 digits) ___________ 
4.  Month published  1  2  3  4  5  6  7  8  9  10  11  12    
5.  Day published (if more than 1 issue per month)  __________ 
6.  Published in (journal name) ______________________________________________ 
7.  Country of journal _____________________________________________________ 
8.  Nationality of sample ___________________________________________________ 
9.  Cross-cultural or multiple nationalities in sample    1    Yes      2  No      9  Don’t know 
Section 2 
Name of 1st author ________________________________________________________ 
10.  Credentials of author:   
1 MD      5   LCSW 
2 PhD     6   LPC 
3 PsyD     7 Other (Specify) ___________ 
4 RN, LPN    9 Don’t know 
11.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
 
Name of 2nd author _______________________________________________________ 
12.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
13.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
       
Name of 3rd author _______________________________________________________ 
14.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
15.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
Name of 4th author _______________________________________________________ 
16.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
  75 
 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
17.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
Name of 5th author _______________________________________________________ 
18.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
19.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
Name of 6th author _______________________________________________________ 
20.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
21.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
Name of last author ____________________________________________________ 
22.  Credentials of author: 
 1 MD     5 LCSW 
 2 PhD     6 LPC 
 3 PsyD     7 Other (Specify) ___________ 
 4 RN, LPN    9 Don’t know 
       10 Not applicable 
23.  Gender of author:  1 Male  2 Female 
9 Don’t know 10 Not applicable 
 
24.  Sponsor of article:  
1 Pharmaceutical company  4 Other (Specify) ___________ 
2 Medical practice     9 Don’t know 
3 Professional organization 
 
Section 3 
What, according to the article, causes PPD? 
Biology 
25.  Hormones?  1  Yes  2  No  9  Don’t know 
26.  Sleep Deprivation? 1  Yes  2  No  9  Don’t know 
27.  Diet?   1  Yes  2  No  9  Don’t know 
28.  Other biological cause? (Specify) ________________________________ 
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    1  Yes  2  No  9  Don’t know 
Psychology 
29.  Prior Depression? 1  Yes  2  No  9  Don’t know 
30.  Stress?   1  Yes  2  No  9  Don’t know 
31.  Coping skills?  1  Yes  2  No  9  Don’t know 
32.  Perfectionism?  1  Yes  2  No  9  Don’t know 
33.  Self-esteem?  1  Yes  2  No  9  Don’t know  
34.  Childhood experiences or trauma?   
    1  Yes  2  No  9  Don’t know   
35.  Other psychological cause? (Specify) _____________________________    
       1  Yes  2  No  9  Don’t know 
Social 
36.  Family support?  1  Yes  2  No  9  Don’t know 
37.  Marital relationship? 1  Yes  2  No  9  Don’t know 
38.  Friends?   1  Yes  2  No  9  Don’t know 
39.  Other social cause? (Specify) ____________________________________  
    1  Yes  2  No  9  Don’t know 
Section 4 
Does the article infer implicitly or explicitly that some individuals are more vulnerable or 
at risk for PPD based on biographical characteristics? 
40.  Age?   1  Yes  2  No  9  Don’t know 
41.  Marital status  1  Yes  2  No  9  Don’t know 
42.  Low SES   1  Yes  2  No  9  Don’t know 
43.  Race   1  Yes  2  No  9  Don’t know 
44.  Ethnicity   1  Yes  2  No  9  Don’t know 
45.  Other biographical characteristics? (Specify)________________________   
    1  Yes  2  No  9  Don’t know 
Section 5 
What, according to the article, are the symptoms of PPD? 
Physical: 
46.  Insomnia    1  Yes  2  No  9  Don’t know 
47.  No energy / fatigue 1  Yes  2  No  9  Don’t know 
48.  Appetite changes   1  Yes  2  No  9  Don’t know 
49.  Headaches   1  Yes  2  No  9  Don’t know 
50.  Chest pains   1  Yes  2  No  9  Don’t know 
51.  Heart palpitations  1  Yes  2  No  9  Don’t know 
52.  Hyperventilating   1  Yes  2  No  9  Don’t know 
53.  Other physical symptoms (Specify) _______________________________ 
    1  Yes  2  No  9  Don’t know  
Emotional:  
54.  Anxiety    1  Yes  2  No  9  Don’t know 
55.  Excessive worry   1  Yes  2  No  9  Don’t know 
56.  Confusion   1  Yes  2  No  9  Don’t know 
57.  Sadness    1  Yes  2  No  9  Don’t know 
58.  Feeling overwhelmed 1  Yes  2  No  9  Don’t know 
59.  Feeling inadequate as a parent  
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    1  Yes  2  No  9  Don’t know 
60.  Incoherence   1  Yes  2  No  9  Don’t know 
61.  Feeling of hopelessness  1  Yes  2  No  9  Don’t know 
62.  Thoughts of suicide  1  Yes  2  No  9  Don’t know 
63.  Hallucinations   1  Yes  2  No  9  Don’t know 
64.  Other emotional symptoms (Specify) _____________________________   
    1  Yes  2  No  9  Don’t know 
Behavioral:   
65.  Crying    1  Yes  2  No  9  Don’t know 
66.  Oversensitivity   1  Yes  2  No  9  Don’t know 
67.  Irritability   1  Yes  2  No  9  Don’t know 
68.  Panic Attacks   1  Yes  2  No  9  Don’t know 
69.  Hostility    1  Yes  2  No  9  Don’t know 
70.  Paranoia    1  Yes  2  No  9  Don’t know 
71.  Other behavioral symptoms (Specify) ____________________________ 
    1  Yes  2  No  9  Don’t know 
Section 6 
Does the article reference a distinction in intensity of PPD? 
72.  Baby blues  1  Yes  2  No  9  Don’t know 
73.  Postpartum Depression 1  Yes  2  No  9  Don’t know 
74.  Postpartum Psychosis 1  Yes  2  No  9  Don’t know 
 
75.  Does the article reference the prevalence of the baby blues (in terms of % of all new 
mothers)? 
 1 Yes (Specify range):  From ____% to _____ % of all new mothers 
 2 No 
 9 Don’t know 
 
76.  Does the article reference the prevalence of PPD (in terms of % of all new mothers)? 
 1 Yes (Specify range):  From ____% to _____ % of all new mothers 
 2 No 
 9 Don’t know 
 
77.  Does the article reference the prevalence of postpartum psychosis (in terms of % of 
all new mothers)?  
 1 Yes (Specify range):  From ____% to _____ % of all new mothers 
 2 No 
 9 Don’t know 
 
Does the article suggest that others can have PPD? 
78.  Father?   1  Yes  2  No  9  Don’t know 
79.  Other family members? (Specify) ________________________________ 
    1  Yes  2  No  9  Don’t know 
80.  Friends?   1  Yes  2  No  9  Don’t know 
 
Section 7 
Does the article suggest an effective treatment for PPD? 
81.  Medication?  1  Yes  2  No  9  Don’t know 
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82.  Counseling?  1  Yes  2  No  9  Don’t know 
83.  Social support?  1  Yes  2  No  9  Don’t know 
84.  Combination (Specify) _____________________________________  
    1  Yes  2  No  9  Don’t know 
85.  Other treatment (Specify) ___________________________________ 
    1  Yes  2  No  9  Don’t know 
 
Section 8 
Does the article mention consequences of PPD?   
86.  Harm to child?  1  Yes  2  No  9  Don’t know 
87.  Harm to mother?  1  Yes  2  No  9  Don’t know 
88.  Harm to spouse?  1  Yes  2  No  9  Don’t know 
89.  Harm to family?  1  Yes  2  No  9  Don’t know 
90.  Harm to society?  1  Yes  2  No  9  Don’t know 
91.  Harm to other (Specify) _______________________________________ 
    1  Yes  2  No  9  Don’t know 
 
92.  Does the article mention extreme cases of PPD (e.g., Yates)? 
    1  Yes  2  No  9  Don’t know 
Section 9 
What is the role of medical professionals in PPD? 
 
Does the article recommend proactive intervention such as 
Screening… 
93.  for new mothers?  1  Yes  2  No  9  Don’t know 
94.  for new fathers?  1  Yes  2  No  9  Don’t know 
 
Educating… 
95.  Mothers?   1  Yes  2  No  9  Don’t know 
96.  Fathers?   1  Yes  2  No  9  Don’t know 
97.  Health care professionals? (Specify) _________________________________ 
    1  Yes  2  No  9  Don’t know 
 
Support  
98.  for new mothers?  1  Yes  2  No  9  Don’t know 
99.  for new fathers?  1  Yes  2  No  9  Don’t know 
100.  for health care professionals? 
    1  Yes  2  No  9  Don’t know 
------------------------------------------------------------------------------------------------------------ 
Comments about the article or selected quotes:    
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Appendix B 
Edinburgh Postnatal Depression Scale (EPDS) 
 Taken from the British Journal of Psychiatry June, 1987, Vol. 150 by J.L. Cox, J.M. 
Holden, R. Sagovsky 
( In www.childbirthsolutions.com ) 
The Edinburgh Postnatal Depression Scale has been developed to assist primary care 
health professionals to detect mothers suffering from postnatal depression; a 
distressing disorder more prolonged than the "blues" (which occur in the first week 
after delivery) but less severe than puerperal psychosis. Previous studies have 
shown that postnatal depression affects at least 10percent of women and that many 
depressed mothers remain untreated. These mothers may cope with their baby and 
with household tasks, but their enjoyment of life is seriously affected and it is 
possible that there are long-term effects on the family.  
The EPDS was developed at health centers in Livingston and Edinburgh. It consists of 
ten short statements. The mother underlines which of the four possible responses is 
closest to how she has been feeling during the past week. Most mothers complete 
the scale without difficulty in less than 5 minutes.  
The validation study showed that mothers who scored above threshold 92.3percent 
were likely to be suffering from a depressive illness of varying severity. Nevertheless 
the EPDS score should not override clinical judgment. A careful clinical assessment 
should be carried out to confirm the diagnosis. The scale indicates how the mother 
has felt during the previous week and in doubtful cases it may be usefully repeated 
after 2 weeks. The scale will not detect mothers with anxiety neuroses, phobias or 
personality disorder.  
Instructions for users:  
1. The mother is asked to underline the response which comes closest to how 
she has been feeling in the previous 7 days. 
2. All ten items must be completed.  
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3. Care should be taken to avoid the possibility of the mother discussing her 
answers with others. 
4. The mother should complete the scale herself, unless she has limited English 
or has difficulty with reading.  
5. The EPDS may be used at 6-8 weeks to screen postnatal women. The child 
health clinic, postnatal check-up or a home visit may provide suitable 
opportunities for its completion.  
**** 
Name: _______________________________  
Address: ___________________________________________________ 
Baby's Age: __________________  
As you have recently had a baby, we would like to know how you are feeling. Please 
UNDERLINE the answer which comes closest to how you have felt IN THE PAST 7 
DAYS, not just how you feel today.  
1. I have been able to laugh and see the funny side of things. 
 
As much as I always could  
Not quite so much now  
Definitely not so much now  
Not at all  
2. I have looked forward with enjoyment to things. 
 
As much as I ever did  
Rather less than I used to  
Definitely less than I used to 
Hardly at all  
3. * I have blamed myself unnecessarily when things went wrong. 
 
Yes, most of the time  
Yes, some of the time  
Not very often  
No, never 
4. I have been anxious or worried for no good reason.  
 
No, not at all  
Hardly ever  
Yes, sometimes  
Yes, very often  
5. * I have felt scared or panicky for not very good reason.  
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Yes, quite a lot  
Yes, sometimes  
No, not much  
No, not at all  
6. * Things have been getting on top of me.  
 
Yes, most of the time I haven't been able to cope at all  
Yes, sometimes I haven't been coping as well as usual  
No, most of the time I have coped quite well  
No, I have been coping as well as ever  
7. * I have been so unhappy that I have had difficulty sleeping.  
 
Yes, most of the time  
Yes, sometimes  
Not very often  
No, not at all  
8. * I have felt sad or miserable.  
 
Yes, most of the time  
Yes, quite often  
Not very often  
No, not at all  
9. * I have been so unhappy that I have been crying. 
 
Yes, most of the time  
Yes, quite often  
Only occasionally  
No, never  
10. * The thought of harming myself has occurred to me.  
 
Yes, quite often  
Sometimes  
Hardly ever  
Never  
Response categories are scored 0, 1, 2, and 3 according to increased severity of the 
symptoms. Items marked with an asterisk are reverse scored (i.e. 3, 2, 1, and 0). 
The total score is calculated by adding together the scores for each of the ten items.  
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Appendix C 
Beck Depression Inventory (BDI) 
Choose one statement from among the group of four statements in each question that best 
describes how you have been feeling during the past few days. Circle the number beside your 
choice.   
1 0 I do not feel sad.  
1 I feel sad.  
2 I am sad all the time and I can't snap out of   
it.  
3 I am so sad or unhappy that I can't stand it. 
8 0 I don't feel I am any worse than anybody else.  
1 I am critical of myself for my weaknesses or 
mistakes.  
2 I blame myself all the time for my faults.  
3 I blame myself for everything bad that happens. 
2 0 I am not particularly discouraged about the 
future.  
1 I feel discouraged about the future.  
2 I feel I have nothing to look forward to.  
3 I feel that the future is hopeless and that 
things cannot improve. 
9 0 I don't have any thoughts of killing myself.  
1 I have thoughts of killing myself, but I would not 
carry them out.  
2 I would like to kill myself.  
3 I would kill myself if I had the chance.  
3 0 I do not feel like a failure.  
1 I feel I have failed more than the average 
person.  
2 As I look back on my life, all I can see is a lot 
of failure.  
3 I feel I am a complete failure as a person. 
10 0 I don't cry any more than usual.  
1 I cry more now than I used to.  
2 I cry all the time now.  
3 I used to be able to cry, but now I can't cry even 
though I want to. 
4 0 I get as much satisfaction out of things as I 
used to.  
1 I don't enjoy things the way I used to.  
2 I don't get any real satisfaction out of 
anything anymore.  
3 I am dissatisfied or bored with everything. 
11 0 I am no more irritated by things than I ever am.  
1 I am slightly more irritated now than usual.  
2 I am quite annoyed or irritated a good deal of the 
time.  
3 I feel irritated all the time now. 
5 0 I don't feel particularly guilty.  
1 I feel guilty a good part of the time.  
2 I feel quite guilty most of the time.  
3 I feel guilty all of the time. 
12 0 I have not lost interest in other people.  
1 I am less interested in other people than I used to 
be.  
2 I have lost most of my interest in other people.  
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3 I have lost all of my interest in other people. 
6 0 I don't feel I am being punished.  
1 I feel I may be punished.  
2 I expect to be punished.  
3 I feel I am being punished. 
13 0 I make decisions about as well as I ever could.  
1 I put off making decisions more than I used to.  
2 I have greater difficulty in making decisions than 
before.  
3 I can't make decisions at all anymore. 
7 0 I don't feel disappointed in myself.  
1 I am disappointed in myself.  
2 I am disgusted with myself.  
3 I hate myself. 
14 0 I don't feel that I look any worse than I used to.  
1 I am worried that I am looking old or unattractive.  
2 I feel that there are permanent changes in my 
appearance that make me look unattractive.  
3 I believe that I look ugly. 
  
  
  
  
15 0 I can work about as well as before.  
1 It takes an extra effort to get started at doing 
something.  
2 I have to push myself very hard to do 
anything.  
3 I can't do any work at all. 
19 0 I haven't lost much weight, if any, lately.  
1 I have lost more than five pounds.  
2 I have lost more than ten pounds.  
3 I have lost more than fifteen pounds.  
(Score 0 if you have been purposely 
trying to lose weight.) 
16 0 I can sleep as well as usual.  
1 I don't sleep as well as I used to.  
2 I wake up 1-2 hours earlier than usual and 
find it hard to get back to sleep.  
3 I wake up several hours earlier than I used 
to and cannot get back to sleep. 
20 0 I am no more worried about my health 
than usual.  
1 I am worried about physical problems 
such as aches and pains, or upset 
stomach, or constipation.  
2 I am very worried about physical 
problems, and it's hard to think of much 
else.  
3 I am so worried about my physical 
problems that I cannot think about 
anything else. 
17 0 I don't get more tired than usual.  
1 I get tired more easily than I used to.  
21 0 I have not noticed any recent change in 
my interest in sex.  
1 I am less interested in sex than I used 
  84 
 
2 I get tired from doing almost anything.  
3 I am too tired to do anything. 
to be.  
2 I am much less interested in sex now.  
3 I have lost interested in sex completely. 
18 0 My appetite is no worse than usual.  
1 My appetite is not as good as it used to be.  
2 My appetite is much worse now.  
3 I have no appetite at all anymore.  
    
SCORING  
1 – 10: These ups and downs are considered normal. 
11 – 16: Mild mood disturbance  
17 – 20: Borderline clinical depression  
21 – 30: Moderate depression  
31 – 40: Severe depression  
over 40: Extreme depression 
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